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CHAPTER I 
INTRODUCTION 
 
An overview of the vasculature 
 The cardiovascular system is the earliest developing functional organ system in 
the yolk sac and embryos of all vertebrate species and is necessary for gas and nutrient 
exchange to support life1-4.  The generation of new blood vessels that comprise the 
cardiovascular system occurs through two similar, but distinct processes: vasculogenesis 
and angiogenesis3, 5-13. Vasculogenesis, also known as de novo tube formation, is the 
process of endothelial cells (ECs) or mesodermally derived angioblasts, also referred to 
as endothelial precursor cells, forming new blood vessels1, 6, 11-14. During this process ECs 
become polarized and undergo lumen formation to generate both an apical and basal 
membrane surface, separating the lumen from the extracellular matrix environment and 
thus establishing a tubular structure that allows for gas and nutrient exchange across the 
cell11, 12, 15, 16. Concurrently, ECs undergoing vasculogenesis also sprout and branch to 
assemble into a multicellular, continuous tube network known as the capillary plexus1, 17, 
18. The capillary plexus is then remodeled through the process of angiogenesis, in which 
new blood vessels are generated through sprouting of ECs from the capillary plexus or 
other established vascular networks5, 6, 8-10. Maturation of these vascular networks then 
occurs through recruitment of mural support cells (i.e. pericytes and smooth muscle cells) 
that help to transition vascular networks from morphogenesis to stabilization through 
structural support as well as establishing basal polarity by vascular basement membrane 
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matrix assembly via EC and pericyte interaction7, 19-24. Recently, substantial interest and 
effort has been made in understanding the molecular mechanisms controlling 
vasculogenesis, angiogenesis, and the signaling events controlling EC and mural cell 
interactions with considerable attention being paid to understanding the mechanisms 
controlling EC lumen formation. Together, these processes are critical in embryonic 
development2-4, 25, the female reproductive cycle26, 27, injury and wound repair28, 29, cancer 
metastases and tumor growth30, 31, and a number of disease states associated with 
ischemia, atherosclerosis, diabetes and genetic mutation as cardiovascular disease 
continues to be a leading cause of death globally32-35.  
 
Regulation of asymmetric cell polarity during lumen formation 
 Cell polarity must be coordinated for individual cells to form into a tissue and 
involves the asymmetric organization of the cell surface, intracellular organelles and the 
cytoskeleton36. Actin filaments and microtubules are polar polymers that comprise the 
cytoskeleton and are composed of globular actin and α- and β- tubulin heterodimeric 
subunits respectively. Cytoskeletal polarity results from the unidirectional assembly of 
these subunits, and these polymers are highly dynamic as each end can either polymerize 
or depolymerize. This unicellular polarity is critical for motor proteins that associate with 
the cytoskeleton and function to traffic vesicles and membrane cargo along oriented actin 
or microtubule arrays. These motor proteins consist of myosins that associate with actin 
and move towards actin barbed ends, kinesins that move towards microtubule plus ends 
and dyneins that moves towards microtubule minus ends in the presence of the dynactin 
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complex, which are often anchored at the centrosome or other microtubule minus-
organizing centers37.  
For actin and microtubules to assemble to into organized arrays, nucleation must 
occur in order to form small oligomers that can rapidly elongate38, 39. The assembly of 
polarized actin arrays is regulated in part by actin nucleation factors such as the actin-
related protein-2/3 (Arp2/3) complex and formin-family proteins activated upstream by 
Rho-family GTPases40, 41, whereas a mechanism of organization of microtubules results 
from cortical capture of microtubule plus ends regulated by proteins associated with 
microtubule plus ends and cortical factors controlled by Rho GTPases42, 43. Furthermore, 
maintenance of polarity and microtubule stability has been associated with differences in 
post-translationally modified tubulins, such as detyrosination, acetylation and 
polyglutamylation as these modifications have been associated with enhanced kinesin-1 
binding to microtubules to facilitate transport processes in neurons and fibroblasts44-47. 
Another component of cellular asymmetry results from centrosome orientation and 
selective stabilization of a subset of microtubules, which serves to position the 
centrosome around the nucleus. Control of this orientation has been associated with the 
activity of Cdc42, partitioning defective protein (PAR)6, atypical protein kinase C 
(aPKC) and dynein48-50. However, Cdc42 effectors including IQ motif- containing 
GTPase-activating protein-1 (IQGAP1), myotonic dystrophy kinase-related Cdc42-
binding kinase (MRCK) and mammalian formin diaphanous-1 (mDia1) have also been 
implicated in controlling centrosome orientation suggesting that the mechanism of 
orientation may depend on cell type or distinct downstream pathways51-53.  
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 The asymmetric distribution of cytoskeletal components and its ability to regulate 
components of polarity signaling is crucial in both endothelial and epithelial de novo 
lumen formation in the mechanism of basal to apical membrane transport11, 12, 15, 36, 37, 54. 
It has been demonstrated in models of epithelial and endothelial lumen formation that 
activity of the Cdc42/Par3/Par6/aPKC complex is required55-57. Interestingly, Par3/Par6 
has been reported to associate with VE-Cadherin, which has a key role in the 
development of the vasculature and serves as the principal EC adherens junction 
molecule and was also shown to be a regulator of EC polarity58-60. It was recently 
reported that acetylated tubulin and detyrosinated tubulins localize at the subapical 
domain of the developing EC lumen and that these tubulin modifications correlate with 
EC lumen formation whereas F-actin is distributed basally. Furthermore, these tubulin 
modifications are controlled by key microtubule tip complex proteins, and the tubulin 
deacetylases HDAC6 and SIRT2 negatively regulate EC tubulogenesis15. Additionally, a 
critical component of endothelial basal polarity is the recruitment of mural cells to the 
abluminal EC surface and the deposition of vascular basement membrane matrix21, 22. 
Thus, multiple regulators control asymmetric polarization necessary for de novo EC 
lumen formation and maintenance of a functional vasculature although many of the 
molecular mechanisms associated with EC polarity are not well understood including 
those controlled by flow. 
 
A comparison of endothelial and epithelial de novo lumen formation 
The mechanism of de novo lumen formation is a critical step that precedes 
tubulogenesis in both the development of the blood filled vasculature consisting of EC 
	 5	
tubular networks, as well as critical tubular structures that characterize epithelial tissues 
such as the kidney, lung and brain. Recently, great advancements in the understanding of 
the molecular mechanisms contributing to lumen formation and tubulogenesis in both 
ECs and epithelial cells have been made from the development of both in vitro models 
utilizing culture of endothelial and epithelial cells in three-dimensional extracellular 
matrix environments and in vivo models investigating the development of the vasculature 
and epithelial tubular structures in D. melanogaster, C. elegans, mice, and zebrafish11-13, 
61-63. From these models, it has become evident that lumen formation consists of a series 
of steps in which cells first become polarized to establish where membrane material will 
be trafficked to develop the lumen area, then growth of the apical membrane surface and 
expansion of the lumen, and finally maturation of the lumen area to the appropriate 
diameter and stabilization of the structure to begin to fulfill its physiological roles. These 
models have identified that lumen initiation, expansion and maturation consists of a 
number of highly coordinated cell signaling events. However, the intricate details of these 
cell-signaling events remain to be well understood and are of great interest.  
 During epithelial lumen formation, work in Madin-Darby Canine Kidney 
(MDCK) 3D cyst models demonstrated that the initial cue for apicobasal polarization 
results from β1 integrin interaction with different protein components of the extracellular 
matrix including laminins, collagens, entactin and perlecan and downstream signaling 
through the GTPase Rac164-66. As these cells are interacting with one another in 
multicellular cysts, intercellular junctions form, consisting of polarized Epithelial (E)-
cadherins that induce the differential distribution of phosphoinositide species to specify 
membrane identity where PtdIns(3,4,5)P3 localizes to the basolateral membrane, while 
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PtdIns(4,5)P2 functions in part to define apical identity55, 67. Additionally, polarity is 
controlled by key Par and Crumbs protein complexes that regulate apical polarity while 
the Scribble protein complex is a regulator of basal polarity. These different polarity 
regulators then have a critical role in the polarized trafficking of membrane vesicles from 
the cell periphery to the apical membrane initiation site, which proceeds to form the pre-
apical patch as vesicles fuse with one another before lumen expansion in a process 
referred to as cell hollowing. In this mechanism, PTEN is recruited to the apical 
membrane by the Cdc42/Par3/Par6/aPKC signaling complex to maintain apical 
PtdIns(4,5)P2  in association with Annexin255. Rab11A and Rab8A positive vesicles were 
then shown to associate with these complexes and control delivery of vesicles to the 
apical membrane initiation site along with exocyst regulators as discussed in additional 
detail below66, 68. 
 In contrast, the identification of polarity regulators controlling de novo lumen 
formation of ECs has proven a significant challenge, as apicobasal markers have been 
difficult to identify. However, previous work has identified a number of GTPase 
regulators controlling EC polarity, as well as the contributions of asymmetric distribution 
of the cytoskeleton and recruitment of mural cells to the abluminal surface as discussed 
above15, 21, 22, 54, 69-71. An important distinction between epithelial cells and ECs is that 
epithelial tubes are specialized for apical secretion or absorption and are thus dependent 
on specialized organization of transmembrane proteins and cytoskeletal components to 
accomplish this task whereas EC-lined tubes are primarily channels for blood flow and 
gas-exchange. Thus, EC requirement for specialized polarity appears to be less compared 
to the epithelium whereas flow forces in contact with the apical membrane surface likely 
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has a major role in EC polarity signaling12. Additionally, EC tubulogenesis in vitro (1-3 
days) is observed to be much more rapid than that of epithelial tubulogenesis (1-2 
weeks)10, 12, 72, 73. In accordance with this observation of ECs rapidly generating lumens 
during tubulogenesis, it has been reported that ECs are able to undergo pinocytic 
intracellular vacuolization to rapidly generate and transport vacuoles from the basal 
membrane to the site of apical lumen formation where they coalesce74-80. Great effort has 
been put forth in investigating the molecular mechanisms controlling pinocytic 
vacuolization and other signaling events during EC tubulogenesis and details of 
significant findings are discussed below. 
 
The endothelial lumen signaling cascade 
An overview of key signaling mechanisms  
 Considering EC lumen morphogenesis and tubulogenesis, a large body of 
research suggests that key cell signaling events include initiation through integrins, 
tyrosine kinase receptors, G-protein coupled receptors and matrix metalloproteinases7, 57, 
70, 73-75, 77, 81-88. These molecules then activate a downstream signaling cascade involving 
kinase activity of protein kinase C (PKC) isoforms and Src family kinase (SFK) 
members, activation of small GTPases that regulate cytoskeletal rearrangements through 
association with downstream GTPase effectors and activation of the Raf-MEK-Erk 
pathway56, 57, 73, 76, 86, 89. These signaling events initiate development of the lumen and 
capillary assembly through membrane trafficking events and digestion of the extracellular 
matrix environment to expand the lumen area as well as allowing for migration of ECs in 
matrix tunnel spaces to assemble into a network of EC tubes by matrix metalloproteinase 
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activity. Additionally, these signaling events are regulated by key microtubule tip 
complex proteins including end binding 1 (EB1), p150Glued and Clasp1 that also help to 
regulate asymmetric EC cytoskeletal polarity through tubulin acetylation and 
detyrosination15.  
 
Integrin and ECM interaction during EC tubulogenesis  
 The extracellular matrix is composed of different families of molecules that 
include glycosaminoglycans and proteoglycans, collagens and non-collagenous 
glycoproteins90 and among the vasculature, these matrix proteins can vary depending on 
the state the vessel is in, e.g., quiescent, injured or angiogenic85, 91. For ECs, the 
extracellular matrix not only serves as a scaffold that is necessary for EC migration, 
survival and proliferation but also as a critical morphogenic cue during vasculogenesis 
and angiogenesis through integrin signaling with extracellular matrix components such as 
the collagens and fibrin/fibronectin28, 74, 75, 77, 82, 85, 87, 88, 91, 92.  The integrins are a major 
cell surface receptor class composed of α- and β- chains that heterodimerize into different 
combinations dependent on ligand interaction with a particular matrix protein. In 
mammalian genomes, 18 different α- chains and 8 different β- chains have been 
identified to assemble into 24 different combinations93, 94. Collagens are of the most 
abundant proteins in the animal kingdom and in collagen type I matrix environments, the 
collagen integrin receptors α1β1 and α2β1 have been identified to be necessary in 
initiating EC tubular morphogenic events74, 90, 95. Furthermore, in fibrin and fibronectin 
enriched matrices that are typically induced in response to tissue injury, α5β1 integrin 
	 9	
was primarily identified to be necessary for EC tubular morphogenesis, whereas a 
possible role for αvβ3 integrin was identified 85, 88.   
 
The role of hematopoietic cytokines, FGF-2 and VEGF signaling in EC 
tubulogenesis 
 Vascular endothelial growth factor (VEGF) has previously been reported to 
control EC tubulogenesis and has been a primary area of focus for the vascular biology 
field in evaluation of its signaling mechanisms downstream of receptor-ligand binding96-
99. However, the dependence of other critical factors that act in concert with VEGF 
during EC tubulogenesis has been difficult to assess due to complexities associated with 
the experimental models used. Interestingly, using defined serum-free culture conditions 
it was demonstrated that VEGF and fibroblast growth factor-2 (FGF-2) addition alone or 
in combination were not sufficient to stimulate EC tubulogenesis in 3D collagen 
matrices. However, the addition of hematopoietic cytokines stem cell factor (SCF), 
interleukin-3 (IL-3) and stromal derived factor-1α with FGF-2 (as FGF-2 is fundamental 
for EC survival, arteriogenesis and branching morphogenesis)98, 100, 101 allowed for EC 
tubulogenesis and capillary assembly in 3D collagen matrices. Additionally, it was shown 
that VEGF and FGF-2 function as critical priming cues that stimulate EC morphogenesis 
in response to the hematopoietic cytokines suggesting that VEGF signaling and 
hematopoietic cytokine signaling are controlling distinct pathways regulating EC 
tubulogenesis.  
A number of studies have documented that ECs can produce SCF and that they 
express its receptor, the tyrosine kinase c-Kit102-104. Upon ligand binding, c-Kit dimerizes 
	 10	
and induces autophosphorylation of tyrosine residues in the cytoplasmic tail resulting in 
the recruitment of a number of signaling molecules controlling various downstream 
pathways. Interestingly, in addition to activation of JAK-STAT pathways, activation of 
SFKs and the Ras-Raf-MEK-Erk pathway are induced in response to c-Kit signaling105, 
and both of these signaling pathways are critical regulators of EC tubulogenesis56, 89. ECs 
have also been reported to express IL-3 receptor106. IL-3 binding to low affinity IL-3Rα 
and subsequent heterodimerization with the common β subunit forms a high-affinity 
receptor that signals through the JAK-STAT pathway, primarily through JAK2 and 
STAT5. However, IL-3 signal transduction is also capable of activating the Ras-Raf-
MEK-Erk kinase cascade107. SDF-1α, a member of the C-X-C cytokines, in turn signals 
through the G-protein coupled receptor CXC4 and activates downstream signaling 
pathways including PI-3 kinase, Rho family GTPases, and the Ras-Raf-MEK-Erk kinase 
cascade108.    
Together, the transduction of signals from these pathways along with FGF-FGFR 
signaling101 suggests that synergistic activation of the Ras-Raf-MEK-Erk kinase cascade 
is critical during EC tubulogenesis. It was also demonstrated that mRNA and protein 
expression of c-Kit, IL-3Rα and CXCR4 were increased in response to priming with 
VEGF and FGF-2, which correlates with a stimulated EC morphogenic response during 
tubulogenesis73 supporting this notion. Because GTPase signaling also activates this 
pathway in concert with Src, which is activated in response to SCF signaling, it is likely 
that these cytokines influence activation of key downstream GTPases involved in EC 
tubulogenesis as well. However, details of this possible molecular mechanism have not 
yet been elucidated.  
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MT1-MMP proteolytic activity is required for the formation of vascular guidance 
tunnels and activation of Cdc42 during EC tubulogenesis 
 The matrix metalloproteinases (MMPs) are a family of enzymes that regulate a 
number of cell processes including ECM degradation, proteolysis of cell surface proteins, 
liberation of growth factors and tissue morphogenesis, including vascularization86, 109-111. 
During EC tubulogenesis, it was shown that MT1-MMP activity is necessary for the 
generation of vascular guidance tunnels within 3D collagen matrices that are necessary 
for EC lumen formation86. Furthermore, these vascular guidance tunnels create space 
within the ECM that allow for the migration of ECs along these surfaces in a MMP-
independent manner that allows for vascular remodeling, and also allows for migration of 
pericytes that are recruited to the EC abluminal surface to stabilize and mature capillary 
networks21, 86. Importantly, MT1-MMP proteolytic activity and subsequent formation of 
vascular guidance tunnels is coordinated with other molecules controlling EC 
tubulogenesis as inhibition of α2 integrin, PKCε and Src blocked tunnel formation86. The 
importance of MT1-MMP proteolytic activity during vascular morphogenesis has also 
been demonstrated in vivo where MT1-MMP deficient mice were found to have severe 
defects in angiogenic responses supporting the critical importance of MT1-MMP in 
vascular development and remodeling112. Critical to MT1-MMP’s function in controlling 
EC tubulogenesis is its association with the GTPase Cdc42. It was shown that Cdc42 and 
MT1-MMP associate in a multiprotein signaling complex with other key regulators of EC 
tubulogenesis and their activity is interdependent with one another in the context of EC 
tubulogenesis in 3D ECM environments. This interdependent relationship was shown by 
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blockade of vascular guidance tunnel formation with siRNA suppression of Cdc42 and in 
contrast, reduced activation of Cdc42 by inhibition of MT1-MMP during lumen 
formation in 3D collagen matrices. However, migration of ECs and activation of Cdc42 
on a 2D surface was not affected by inhibition of MT1-MMP activity57. Because of MT1-
MMP’s necessity during EC tubulogenesis and vascular morphogenesis, it is likely that 
MT1-MMP activity influences and controls other key signaling mechanisms downstream. 
 
Src family kinase and protein kinase C activity in controlling EC tubulogenesis 
Targets of signal transduction downstream of the integrins and key receptors 
include the SFKs113-115 comprised of nine members including Src, Fyn, Yes, Lck, Hck, 
Blk, Fgr, Lyn and Yrk116. The SFKs are a family of non-receptor protein tyrosine kinases 
that regulate a number of signaling transduction pathways downstream of integrins, 
receptor protein tyrosine kinases, G Protein-coupled receptors, cytokine receptors and 
others. SFKs become active in these signal transduction pathways by phosphorylation of 
the Y416 site and dephosphorylation of the inhibitory Y527 site116.  In human endothelial 
cells, the more prominently expressed SFKs include Src, Yes, Fyn, and Lyn89 and it was 
previously demonstrated that the tyrosine phosphorylation activity of Src is critical 
during EC tubular morphogenesis in vitro89, 117 and in vivo118, 119.  
 In addition to activation by integrins during EC tubular morphogenesis, the PKC 
isoform PKCε was demonstrated to be an activator of Src signaling and subsequent 
downstream tyrosine phosphorylation events of ECs suspended in 3D collagen 
matrices89. The PKC isoforms comprise a family of serine/threonine kinases that are 
divided into three different subfamilies based on differences in NH2-terminal regulatory 
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domain structure. The conventional isoforms, PKCα, PKCβI and the alternatively spliced 
PKCβII and PKCγ contain a regulatory domain termed C1 that functions as a 
diacylglycerol (DAG)-/phorbol 12-myristate 13-acetate (PMA and also known as TPA)-
binding motif. Additionally, these isoforms also contain a regulatory domain termed C2 
that binds anionic phospholipids in a process that is calcium-dependent. The novel PKC 
isoforms, PKCδ, PKCθ, PKCε and PKCη, also contain a similar C1 domain that 
functions as a DAG-/TPA-binding motif and a similar C2 domain. However, the C2 
domain of novel PKC isoforms lack the critical calcium coordinating acidic residues and 
thus novel PKCs are primarily activated by agonists that promote DAG accumulation or 
TPA with no calcium requirement. The atypical PKC isoforms, PKCζ and PKCι/λ, lack a 
C2 domain and possess an atypical C1 domain that binds phosphatidylinositol (3,4,5)-
triphosphate (PIP3) and ceramide. Their regulatory region also contains a unique domain 
from the other PKC subfamilies known as the Phox and Bem 1 (PB1) that mediates 
interactions with other proteins containing PB1120.  
 A number of previous studies have implicated that TPA strongly stimulates EC 
morphogenic events both in vitro74, 121-123 and in vivo124. A combination of chemical 
inhibitor and siRNA mediated RNA interference experiments then identified critical roles 
for novel PKCε and atypical PKCζ during EC tubulogenesis in 3D collagen matrices56. 
During EC tubulogenesis, PKCε kinase activity was shown to be necessary for activation 
of Src kinase signaling, which activates the Raf-Mek-Erk1/2 kinase cascade through 
activation of the p21 activated kinases (PAKs) PAK2 and PAK489. In addition to integrin, 
SFK and PKC regulation of EC tubulogenesis, a continually growing amount of evidence 
has implicated a critical role for regulation of this morphogenic process by members of 
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the Ras superfamily of GTPases and several studies have identified key relationships 
between GTPase activity and that of integrin, SFK, and PKC signaling during EC 
tubulogenesis56, 57, 89.  
 
The role of Ras superfamily GTPase regulation of endothelial lumen 
formation and vessel stabilization 
An overview of Ras superfamily GTPases 
 The Ras superfamily of GTPases is comprised of over 150 members that are 
separated into five families based on sequence and function similarity: Ras, Rho, Rab and 
Ran, Arf (Figure 1.1). These proteins function as monomeric G proteins that share a 
similarity to the heterotrimeric G protein α subunits and possess a common biochemical 
mechanism in acting as GDP/GTP-regulated molecular switches. A number of these 
GTPases also contain post-translational lipid modifications that serve to direct these 
proteins to various subcellular locations to execute their functions. The majority of these 
GTPases possess an intrinsic ability of GTP hydrolysis to GDP and cycling between 
GTP- or GDP-bound states is regulated by two additional classes of proteins, guanine 
nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs)125, 126. An 
additional form of regulation for the Rab and Rho family of GTPases comes from 
association with guanine nucleotide dissociation inhibitors (GDIs), which function to 
sequester these GTPases in the cytosol127, 128. GTPases are capable of associating with a 
number of different downstream effector molecules to regulate a variety of cellular 
processes such as proliferation, cell polarity, migration, membrane trafficking and 
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morphogenesis125, 126 and in the Rho family for example, identification of GTPase 
effectors has been a significant challenge since a majority of the effectors do not have a 
conserved domain128, 129. In addition to association with a variety of effector molecules, 
individual GTPases are also regulated by several GEFs and GAPs that may have more 
than one GTPase target and thus demonstrate the complexity of GTPase signaling in 
regulation of cellular processes130.  
 
Rho-family GTPase regulation of cytoskeletal organization, cell polarity and lumen 
formation 
 Among the most well studied GTPases are the Rho family members Cdc42, Rac1, 
and RhoA. Studies in the early 1990s identified these particular GTPases to be regulators 
of the actin cytoskeleton131-134 and global deletion of Cdc42 and Rac1 in vivo resulted in 
lethality at early stages demonstrating a critical function for these GTPases during early 
development135, 136. In response to different extracellular cues, RhoA was shown to 
promote the formation of actin stress fibres131, while Rac1 activation promoted the 
formation of lamellipodia/membrane ruffles132. Shortly thereafter, other studies 
demonstrated that upon activation Cdc42 induced actin-rich microspikes, known as 
filipodia, at the cell periphery and also activated Rac activity via lamellipodia 
formation133, 134. Through great effort, work in the mid-1990s identified between 20 and 
30 potential downstream targets that interact with Cdc42, Rac1, and RhoA in a GTP-
dependent manner and revealed that these GTPases were capable of regulating several 
cellular signaling pathways129. One of the earliest identified downstream effectors for 
Cdc42 and Rac1 were PAKs137 and shortly thereafter Rho-associated kinase (ROCK) was 
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identified as a downstream effector of RhoA that activates myosin II by phosphorylation 
and inactivation of myosin light chain phosphatase138, 139. Cdc42 was also shown to be a 
key regulator of cell polarity and establishing asymmetry during epithelial 
morphogenesis, asymmetric cell division and directed cell migration events through its 
association with a Par6-PKCζ complex55, 140-144. Because of the critical role for these 
GTPases in regulation of actin reorganization and cell polarity, there has been great 
interest in understanding how these molecules may regulate tube morphogenesis events 
and cytoskeletal reorganization in both endothelial and epithelial tissues.  
 A necessary requirement for Cdc42 and Rac1 activity during tubulogenic 
morphogenesis events was first identified in vitro utilizing ECs suspended in 3D collagen 
or fibrin matrices under stimulation of TPA whereas a role for RhoA during these events 
was not supported76, 77. Additional work utilizing ECs undergoing tubulogenesis in 3D 
collagen matrix environments has demonstrated that Cdc42 associates with PAK2, 
PAK4, Par3, Par6B56, 57, members of the junction adhesion molecule (Jam) family JamB 
and JamC, α2 integrin, MT1-MMP57 and Src89 in signaling complexes that function to 
activate the Raf-MEK-Erk1/2 kinase cascade, establish apical and basal polarity and 
promote lumen morphogenesis in conjunction with PKC activity56, 57, 89 (Figure 1.2). 
Recent evidence in vivo has also demonstrated a critical role for Cdc42 in the initiation of 
lumen formation as well as maintenance of tube structures by utilizing an inducible 
endothelial specific knockout model where EC adhesion, polarity and vascular 
remodeling ability are impaired, implicating that Cdc42 activity is critical in both 
vascular development and maintenance145. Similarly, endothelial specific deletion of 
Rac1 results in vascular development defects146. Work in vitro and in vivo has also shown 
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that Cdc42 activity and association with Par6/atypical PKC is required for lumen 
formation and trafficking of vesicles to the apical membrane during epithelial tube 
morphogenesis in MDCK cyst models in differing ECM environments55, 66, 147, 148 and in 
the developing pancreas149. Rac1 function has also been characterized in epithelial tube 
morphogenesis events where expression of DN Rac1 inversed polarity, inhibited lumen 
formation and resulted in misassembled laminin at the basement membrane64 and Rac1 
functions downstream of β1 integrin signaling during this process to properly orient 
epithelial cell polarity65, 150. Additionally Rac1, and not Cdc42, is needed for epithelial 
tight junction formation151. Therefore, in both endothelial and epithelial tissues, Cdc42 
and Rac1 possess similar functional requirements in promoting lumen morphogenesis 
although details of the molecular signaling events regulated by these two GTPases are 
still the focus of ongoing investigation.   
 Conversely, a number of studies suggest that activation of RhoA signaling impairs 
tubulogenesis events in both endothelial and epithelial tissues. Evidence from in vitro 
studies of endothelial lumen formation demonstrated that delivery of a constitutively 
active (CA) form of RhoA by recombinant adenovirus infection inhibited tubulogenesis 
and induced EC death76. It was also shown that inhibition of EC lumen formation through 
the use of microtubule disrupting agents, e.g. vinblastine, colchicine and nocodazole, is 
dependent on activation of RhoA signaling where pretreatment of ECs with C3 
exoenzyme or recombinant adenovirus delivery of dominant negative (DN) RhoA 
completely blocked induced tube collapse152. Furthermore, Erk-MAPK kinase activity 
and Src kinase activity were identified to suppress Rho-ROCK signaling during EC 
morphogenesis events in vitro and in vivo117, 153. In addition to regulation by these kinase 
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signaling pathways, upstream regulation of RhoA activity during EC tubulogenesis is 
controlled by the GTPase effector Rasip1, which is highly expressed in ECs, and its 
association with the RhoGAP Arhgap29. Rasip1 null mice exhibit vascular defects in 
early development where ECs assemble into cord-like structures where the lumen fails to 
develop. In vitro studies of Rasip1 or Arhgap29 knockdown during vasculogenesis in 3D 
collagen matrices recapitulated these results and demonstrated increased detection of 
endogenous active RhoA-ROCK signaling by detection of downstream phosphorylated 
myosin phosphatase targeting subunit (pMYPT) as well as increased detection of 
phosphorylated myosin light chain (pMLC)154. In further support of suppression of Rho-
ROCK activity during lumen morphogenesis events, studies in epithelial models of lumen 
formation have shown that a β1 integrin/focal adhesion kinase (FAK)/p190A RhoGAP 
complex functions to positively regulate epithelial lumen formation by repressing RhoA 
signaling155. Additionally, chemical inhibition of ROCK by the drug Y-27632 is able to 
rescue polarity and lumen defects induced by use of anti-β1 integrin blocking antibody or 
DN Rac1 expression in MDCK cyst models150. Therefore, it is evident that during early 
lumen morphogenesis events, a critical balance must be maintained in order to activate 
Cdc42 and Rac driven signaling and inhibit RhoA signaling.  
 
Ras superfamily members implicated in endothelial morphogenesis and vessel 
integrity 
 Although considerable attention has been focused on the investigation of the role 
of the classic Rho-family GTPases during early EC tubulogenesis and vessel maturation, 
a number of studies have focused on the role of additional Ras superfamily members. A 
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recent study showed that a target of the transcription factor ERG, which is a member of 
the ETS family of transcription factors highly enriched in endothelial cells, is the GTPase 
RhoJ. RhoJ activity was shown to be necessary during early vasculogenesis events and to 
regulate phosphorylated activation of critical downstream kinases in the lumen-signaling 
cascade such as PAK2, PAK4, B-Raf, C-Raf, Src and ERK through association in 
multiprotein signaling complexes with Cdc42156. Of additional interest is the role of Rap1 
isoforms, Rap1A and Rap1B, during endothelial morphogenic events157. Global deletion 
of Rap1A or Rap1B in mouse models have resulted in partial embryonic lethality 
phenotypes characterized by bleeding and edema and impaired angiogenesis158-162, while 
combined deletion of Rap1A and Rap1B resulted in embryonic lethality between E8.5-
E10.5 due to major malformation157. However, endothelial-lineage restricted deletions 
using a Tie2-Cre driven model demonstrated impaired angiogenesis phenotypes among 
an otherwise normal lifespan when both alleles of Rap1B were deleted162. In contrast, 
Tie2-Cre deletion of both alleles in Rap1A and Rap1B resulted in embryonic lethality 
due to hemorrhage between E10.5-E13.5 showing that at least one Rap1 isoform is 
required for normal vascular development and that there may be redundancy in function 
between the two isoforms157. Morpholino mediated inhibition of Rap1B expression 
during zebrafish development also lead to vascular malformations, recapitulating roles 
for Rap1B function during mouse development157, 162, 163.  
Work from cellular models investigating the role of Rap1 in the endothelium has 
identified a primary functional role for Rap1 in the stabilization of cell-cell junctions. 
Evidence for the molecular mechanism of this function has shown that Rap1 associates 
with Afadin and regulates adherens junction formation. Deletion of Afadin in the 
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endothelium utilizing a Tie2-Cre driven system showed a markedly impaired 
angiogenesis phenotype in the retina and the postnatal viability of the homozygous 
knockout mice in this model is greatly reduced, implicating the role of Rap1-Afadin 
activity in other aspects of vasculogenesis164.  
Another Rap1 effector identified to be a critical regulator of vascular 
morphogenesis and integrity is KRIT1, or CCM179, 165. Cerebral cavernous 
malformations (CCMs) are vascular defects of the central nervous system observed as 
brain angiomas that are susceptible to hemorrhaging and can lead to seizure or stroke166. 
In addition to mutations in CCM1/KRIT1167, 168, two other loci have been implicated in 
autosomal forms of CCM including CCM2/OSM/malcavernin169 (where evidence has 
shown Rac1 as a binding partner)170  and CCM3/PDCD10171. Importantly, it was shown 
that endothelial Rap1 activity is necessary for KRIT1’s interaction with junctional 
molecules172 where KRIT1 binds Heart-of-glass (HEG1) receptor173 and associates with 
junctional molecules such as β-catenin and Afadin174. Recent studies have also shown 
evidence that active Rap1 associates with Rasip1 and its binding partner Arhgap29 to 
negatively regulate RhoA activation and positively regulate endothelial barrier activity 
implicating a role for this signaling cascade in stabilization of the endothelium175-177. 
Furthermore, CCM2 was shown to be required for EC tubulogenesis in vitro and 
homozygous CCM2 mutated mice become lethal during mid-gestation due to defects in 
angiogenesis and vascular patterning. Importantly, loss of CCM2 was shown to induce 
formation of actin stress fibers and activate RhoA178 and this supports the conclusion that 
regulation of GTPase activity is critical in different vascular morphogenesis events. 
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While several GTPases have been identified to have essential functions for 
development and maintenance of the endothelium, the role for many other Ras 
superfamily GTPases members has not been elucidated. A significant amount of work 
has identified critical molecular mechanisms of GTPase regulation of early 
vasculogenesis events, yet this has been primarily limited to the Rho family members 
Cdc42, Rac1 and RhoA and further investigation is required to understand the 
contribution of other novel GTPase regulation of EC tubulogenesis and vascular 
maturation. Furthermore, the molecular mechanisms controlling the regulation of GTPase 
signaling through GEF or GAP activity are not well understood and continued work is 
required to identify and understand the role of key GTPase regulators during 
tubulogenesis and the mechanisms controlling regulation of their activity.  
 
Figure 1.1. The Ras superfamily of small GTPases. Reproduced with permission. Journal 
of Cell Science126. http://jcs.biologists.org/content/118/5/843 
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Figure 1.2. Cdc42-associated molecular signaling complexes control EC lumen 
formation and tubulogenesis in 3D collagen matrices. 
 
Regulation of membrane trafficking events in lumen formation 
Advancements in imaging techniques have identified that ECs suspended in 3D 
matrices are able to undergo rapid intracellular vacuolization and coalescence of these 
vacuole structures to form the lumen during tubulogenesis74-78, 179. Of importance is that 
these structures have been observed in vivo as well12, 21, 78-80, 87, 180, 181. Although this is not 
the only observed mechanism of EC lumen formation in vitro and in vivo11-13, 61, 182, this 
mechanism represents a way in which individual ECs are able to quickly generate lumens 
and assemble into multicellular tube structures to support the needs of embryonic 
development12. What has been observed and described in vitro is a process similar to 
macropinocytosis in which large areas of basal membrane are pinocytosed and trafficked 
to the nascent apical membrane position where coalescence of the pinocytic vacuoles 
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occurs as the lumen develops and expands74, 75, 179. There is also evidence for fusion of 
other intracellular vesicles with pinocytic vacuoles during EC lumen formation as 
Weibel-Palade bodies (WPBs) secretory granules were observed to fuse and transfer their 
contents (e.g. von Willebrand factor) into early vacuole and lumen structures74, 77. While 
there is evidence for observation of these structures during lumen formation, the 
mechanism of how these vacuoles are generated, trafficked in a polarized manner and 
fuse with one another to form the lumen is not well understood. Furthermore, little is 
known about the contribution of other membrane vesicles, such as endosomes, exosomes 
and caveolae to endothelial lumen formation and continued work is required to elucidate 
their role. 
Endocytosis describes the de novo production of intracellular membrane 
compartments from the plasma membrane phospholipid bilayer whereas exocytosis 
describes the opposite process of transportation of internal membrane compartments to 
the plasma membrane surface. A number of different endocytic mechanisms have been 
described in mammalian cells such as clathrin mediated183, 184 and clathrin-independent 
endocytosis, caveolae/caveolin-1 dependent mechanisms, macropinocytosis, 
phagocytosis185-187 and others188. Interestingly, Rac189, PAK190 and Src kinase activity191 
have been associated with the generation of macropinsomes and their necessity during 
EC lumen formation may be in part related to the generation of these macropinocytic 
membrane compartments. ECs are also one of the cell types with the highest expression 
of caveolin-1192. Knockdown of caveolin-1 in ECs using antisense oligonucleotides 
reduced capillary formation in vitro in 3D fibrin gel assays and in vivo in the 
chorioallantoic membrane system of chick embryos193, whereas increased expression of 
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caveolin-1 increased capillary-like assembly in an in vitro Matrigel system194. Many 
proteins have been identified to associate with caveolae in endothelial cells195 including 
critical regulators of endothelial lumen formation and tubulogenesis such as Src, Yes192, 
196, Raf197 and MEK192 and together these results implicate an important role for 
caveolae/caveolin-1 dependent trafficking mechanisms in EC function.  
 With the vast number and variety of membrane vesicles containing various cargo 
comes a requirement for a highly organized and regulated system to deliver these vesicles 
to specific locations in the cell. The largest family of the Ras superfamily of GTPases is 
the Rab GTPase family and its members primarily regulate the coordination of these 
membrane trafficking events198-202. In humans, there are currently more than 60 identified 
Rab members that are localized to distinct intracellular membrane compartments 
associated with the early endosome, recycling endosome, late endosome, trans-golgi 
network, secretory vesicles and others as shown in an epithelial cell represented in Figure 
1.3199, 201, 203, 204. Studies of epithelial morphogenesis and lumen formation have identified 
that Rab11a activity and downstream activation of Rab8a via its GEF Rabin8 are 
necessary for establishment of polarity and lumen formation62, 68, 205-208 and this process is 
dependent on association with Myosin Vb motor protein to properly traffic vesicles to the 
apical membrane initiation site209. Because of the observed Rab requirement for lumen 
formation in epithelial models of morphogenesis and the observations of organized 
membrane trafficking of pinocytic vacuoles in EC lumen formation, investigation into the 
role of Rab GTPases and other membrane trafficking regulators during EC lumen 
formation and tubulogenesis is of great importance.  
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Figure 1.3. Localization and function of Rab GTPases in an epithelial cell. Reprinted by 
permission from Macmillan Publishers Ltd: Nature Reviews Molecular Cell Biology201, 
copyright 2009.	http://www.nature.com/nrm/index.html 
 
Mechanisms of exocytic vesicle fusion controlled by GTPase activity 
 Critical to the development of the lumen and apical membrane surface during 
lumen formation in both ECs and the epithelium is the fusion of vacuoles and vesicles to 
create a single luminal area11, 12, 36, 68, 69. Important to this process is addressing how these 
polarized membrane compartments are able to associate with one another and combine 
lipid bilayers in formation of the apical membrane surface and maintenance of 
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asymmetrical cell polarity. Recently, it was reported in MDCK cyst models of epithelial 
lumen formation that synaptotagmin-like protein (Slp)2-a localizes to the luminal 
membrane in a PtdIns(4,5)P2-dependent manner, where it functions to target Rab27 
positive vesicles to initiate formation of a single lumen. Vesicle tethering to the apical 
membrane and fusion of vesicles is then controlled by Slp4-a in conjunction with 
Rab27/Rab3/Rab8 and the SNARE syntaxin-3210. This mechanism then acts in 
coordination with a Rab11A/Rab8A cascade and its effectors, including the exocyst, to 
form a de novo apical lumen membrane by exocytic delivery and fusion of vesicles68. 
 Slps1-5 are Rab effectors involved in regulation of exocytosis and contain an 
amino-terminal Rab-binding domain i.e., the Slp homology domain, and tandem carboxy-
terminal C2 domains involved in Ca2+ and phospholipid binding, which function in 
tethering secretory vesicles to the plasma membrane211, 212. Furthermore, these tandem C2 
domains are homologous to the C2A and C2B domains of synaptotagmins, and 
expression of most synaptotagmins is highest in neuronal tissues212, 213. Many of these 
synaptotagmin members function by assisting soluble N-ethylmaleimide-sensitive fusion 
protein attachment protein receptors (SNAREs) in Ca2+-dependent exocytosis214. SNARE 
superfamily proteins are critically involved in many intracellular membrane-fusion events 
and consist of SNARE motifs that comprise a highly stable four-helix bundle designated 
as the SNARE complex within the SNARE protein215, 216. During fusion events, at least 
one SNARE protein that contains a transmembrane domain must be present in each of the 
membranes undergoing fusion with one another. The SNARE complex then forms in a 
trans configuration where the SNAREs involved in the formation of the complex are 
localized in different membranes. Then the complete SNARE complex is formed, which 
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results in a cis complex in which all of the contributing SNAREs are localized in the 
same membrane and this complete complex formation temporally coincides with 
membrane fusion. The complex is then disassembled to free SNAREs for other fusion 
events212. 
 In endothelial cells, it has been reported that Rab27A associates with WPB 
secretory granules that are released from the endothelium into the blood in response to 
thrombosis and inflammation217, 218. Previous work investigating the mechanisms of 
endothelial lumen formation reported that von Willebrand Factor (VWF), a component of 
WPBs219, was present in pinocytic vacuoles suggesting that WPBs may be degranulating 
in these vacuoles as part of an exocytic mechanism potentially involved in lumen 
formation74. Addressing the regulation of WPB exocytosis, it was recently demonstrated 
that WPBs recruit Slp4-a and this involves Rab27A and Rab3B where Slp-4a acts as a 
positive regulator of WPB exocytosis. However, results from this study suggest that WPB 
exocytosis is dependent on Rab27A in this mechanism as knockdown of Rab27A 
inhibited VWF secretion whereas depletion of Rab3B had no effect220. Additionally, 
recent evidence has demonstrated that Slp-4a is a binding partner of syntaxin-binding 
protein 1 (STXBP1) and the SNAREs syntaxin-2 and -3 in endothelial cells suggesting 
that a Rab27A-Slp-4a complex promotes WPB exocytosis through its interaction with 
STXBP1. In addition to Rab isoforms, the small GTPase RalA has also been reported to 
associate with WPBs221, 222 and control its secretion through its effectors Sec5 and Exo84, 
which are members of the exocyst complex223, 224. While it is necessary during 
endothelial lumen formation for trafficked membrane vacuoles/vesicles to coalesce to 
form a nascent lumen, the molecular mechanism of these fusion events is poorly 
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understood. However, given the similarities between regulators controlling exocytic 
mechanisms in both epithelial and endothelial cells it is probable that these mechanisms 
serve a function during EC tubulogenesis. 
 
The importance of integrating in vitro and in vivo models in 
investigating mechanisms of vascular development and regulation 
 Considerable progress has been made in our understanding of the molecular 
events controlling the development of the vasculature and how it is regulated postnatally, 
particularly in contexts of tissue injury, tumorigenesis and other diseases associated with 
cardiovascular abnormalities8, 9, 11, 12, 69, 97. Importantly, much of what has been elucidated 
and advanced the field of vascular biology has resulted from studies both in vitro and in 
vivo that have identified basic cellular mechanisms underlying survival, proliferation, 
migration, invasion and morphogenesis. As Cre recombinase and other gene editing 
technologies, such as CRISPR-Cas9, are becoming more advanced and specific, it has 
become possible to investigate and identify the functional requirement of key molecules 
during vascular development and regulation during postnatal life in the context of a 
multicellular organism. However, complications in vivo can arise from phenotypic 
lethality in knockout models or from the contributions of other tissues that may make it 
difficult to assess specific molecular mechanisms controlling vascular morphogenesis and 
vascular integrity/maintenance. Additionally, it is very difficult to assess the earliest 
events of vasculogeneis in these models. Therefore, it is critical to also utilize in vitro 
models under highly defined conditions, as highlighted here, in order to elucidate the 
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molecular mechanisms controlling these pathways. These in vitro models offer the 
advantage of highly specific manipulation of molecules singly or in combination that can 
be observed to directly affect processes such as EC vasculogenesis, angiogenic sprouting 
from EC monolayers, pericyte recruitment and vascular regression12, 69, 70. By integrating 
studies using both in vitro and in vivo systems, significant advancements can be made in 
identifying targets for therapy in a number of different disease states.  
 
Summary 
 From the onset the goal of this thesis work was to identify and determine the 
novel role of small GTPases of the Ras superfamily and their upstream regulators and 
downstream effectors during EC tubulogenesis. An extensive number of studies suggest a 
critical role for the Rho-family GTPases Cdc42 and Rac1 in promoting EC tubulogenesis 
through key downstream effectors such as PAK2, PAK4, Par3 and Par6b while activation 
of RhoA-ROCK activity inhibits the ability of ECs to form tubes during early 
morphogenesis events56, 57, 76, 89, 145, 152, 154. However, the role of other GTPases such as 
Ras and other Ras-related proteins that are upstream of the Raf-MEK-Erk kinase cascade 
or that have been implicated in stabilization of the endothelium have not been well 
characterized during EC tubulogenesis. To this end, we have identified novel roles for the 
GTPases Rac2, k-Ras, and Rap1B in addition to Cdc42 and Rac1 in EC tubulogenesis. 
Additionally, we identified key functional roles for the downstream effectors IQGAP1, 
MRCKβ, β-Pix and GIT1 and we also have identified key negative regulators of EC 
tubulogenesis as the GAPs Arhgap31, a Cdc42/Rac GAP, and RASA1, a Ras GAP. 
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 Finally, of critical importance during EC lumen formation is understanding the 
mechanism of directed membrane trafficking during early morphogenesis events to form 
a tube structure and establish apical basal polarity; i.e. what controls generation of 
pinocytic intracellular vacuoles, polarized trafficking from the basal membrane to the 
apical membrane, fusion of the vacuoles into a lumen and finally what roles do other 
regulators of vesicle trafficking have during these events (Figure 1.4)? It has been 
observed that Rac1189 and Src191 activity are involved in generation of macropinosomes 
while Cdc42 and Rac1 have been observed to label intracellular vacuole structures during 
EC lumen formation77, 78, 179. Interestingly, recombinant adenovirus expression of GFP-
RalA in lumen forming ECs labeled intracellular vacuoles as well12, 70. Furthermore, 
studies have now shown a critical role for both Rab11A and Rab8A during epithelial 
morphogenesis by demonstrating that these GTPases were necessary for proper 
trafficking of vesicles to the apical membrane initiation site62, 68, 205-209. Therefore it may 
be hypothesized that key regulators of EC lumen morphogenesis, such as Cdc42, Rac1 
and Src may be required for generation of intracellular vacuoles while Rab and Ral 
GTPase activity may function to direct trafficking of these vacuoles and other vesicles to 
the proper site and may control the fusion of vacuoles/vesicles to form a lumen. To 
address this, we have performed a siRNA-mediated knockdown screen investigating the 
roles of Rab and Ral GTPases, which are primarily involved in regulation of endocytic 
and exocytic membrane trafficking events, during early EC tubulogenesis as well as 
caveolin-1, which is associated with caveolae. Additionally, we also developed a number 
of recombinant-adenovirus tools that express fluorescent fusion proteins that were used in 
combination with confocal microscopy analysis to assess the localization of key 
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molecules to vacuoles, vesicles and the apical membrane surface during EC lumen 
morphogenesis. With these studies and additional studies utilizing chemical inhibitors, 
we address the roles of critical regulators of intracellular vacuole formation, polarized 
trafficking and vacuole/vesicle fusion events in controlling EC tubulogenesis in ongoing 
studies.  
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Polarized trafficking and fusion of pinocytic intracellular vacuoles and 
membrane vesicles creates the apical luminal area during endothelial tubulogenesis.  
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ABSTRACT 
 
 Here, we identify major co-regulators of endothelial cell (EC) lumen formation 
including Cdc42 and k-Ras, their downstream effectors, IQGAP1, MRCKβ, β-Pix, and 
Rasip1, and their negative regulators, Arhgap31 and Rasa1.  Multiprotein complexes 
containing these molecules as well as other key regulators including α2β1 integrin and 
MT1-MMP can be shown to assemble during these events.  Human EC siRNA 
suppression or mouse knockout of Rasip1 leads to identical phenotypes where ECs form 
extensive cord networks, but cannot generate lumens or tubes.  Essential roles for these 
molecules during EC tubulogenesis include; i) establishment of asymmetric EC 
cytoskeletal polarization (subapical distribution of acetylated tubulin and basal 
distribution of F-actin); and ii) directed membrane trafficking of pinocytic vacuoles or 
other intracellular vesicles to the developing apical membrane surface.  Cdc42 co-
localizes subapically with acetylated tubulin and Rac1 strongly labels vacuole/ vesicle 
membranes, which accumulate and fuse together in a polarized, pericentrosomal manner.  
Overall, we observe apical membrane and subapical accumulation of key GTPases and 
effectors regulating EC lumen formation including Cdc42, Rac1, Rac2, k-Ras, Rap1b, 
activated c-Raf and Rasip1 to control EC tube network assembly.        
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INTRODUCTION 
 
In recent years, considerable progress has been made toward our understanding of 
vascular morphogenesis, including the subject of this manuscript, which addresses how 
endothelial cells form tube networks with defined lumens 1-6.  Previous work has shown 
the critical importance of integrins, membrane-type matrix metalloproteinases (MT1-
MMP), Rho GTPases, particularly Cdc42 and Rac1, small GTPase regulators such as 
Rasip1, kinase cascades involving PKCepsilon (PKCε), Src family members, Pak2, Pak4, 
Raf, Mek and Erk, and the cytoskeleton 3-5, 7-13.  Other interesting EC lumen regulators 
are proteins such as the cerebral cavernous malformation (CCM) proteins, CCM1, 
CCM2, CCM2L, and CCM3, as well as the polarity proteins, Par6b, Par3 and junctional 
adhesion receptors with affinity for Par3 including JamB, JamC and VE-cadherin 4, 8, 14-19.  
An important direction of this work is to understand how ECs become polarized during 
lumen formation 20.  The role of polarity regulators has been demonstrated (i.e. Cdc42, 
Par6b, Par3), but how this contributes to the development of an EC apical surface and 
polarized cytoskeletal apparatus remains unclear.   
We recently demonstrated that EC lumen formation in 3D matrices results in part 
due to the establishment of asymmetric cytoskeletal polarization with F-actin expressed 
in a basal fashion and with modified tubulins including acetylated and detyrosinated 
tubulin localized in a subapical domain to support the developing apical membrane 
surface 21.  Key plus-end microtubule regulatory proteins, EB1, p150glued and Clasp1, 
control EC lumen formation through the subapical polarization and expression levels of 
these modified tubulins 21.  In part they act together to negatively regulate the tubulin 
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deacetylases, HDAC6 and Sirt2.  siRNA suppression of these deacetylases singly or in 
combination, led to increased EC lumen formation, while increased expression of 
HDAC6 and Sirt2 interfered with lumen formation 21.  In addition, disruption of 
microtubules with colchicine or other agents such as the chemotherapeutic drug, 
vinblastine, caused EC tube disassembly and collapse and importantly, there is also rapid 
loss of tubulin acetylation and activation of RhoA.  Thus, tubulin modifications are major 
regulators of EC lumen formation, but also lumen and tube maintenance via support of 
the apical membrane domain 21, 22. 
 Here, in this new study, we have characterized the role of other small 
GTPases, downstream effectors, and key GTPase activating proteins (GAPs) that 
negatively regulate the EC lumen and tube formation process.  Our studies have 
identified important new roles for Cdc42, Rac2, k-Ras and Rap1b and siRNA suppression 
of Cdc42 in combination with these other three GTPases causes profound inhibition of 
EC tubulogenesis.  Furthermore, we have identified Arhgap31 and Rasa1 as GAPs that 
interfere with Cdc42, Rac, and k-Ras, markedly blocking the lumen formation process.  
In contrast, Arhgap29, a Rho-specific GAP, does the opposite and actually stimulates EC 
tube assembly through its RhoA-inhibitory activity.  Additionally, we identify a novel 
role for downstream effectors of these GTPases including IQGAP1, MRCKβ, β-Pix, 
GIT1, and Rasip1 during this process.  Finally, we investigate EC polarization during 
lumen formation and demonstrate the apical targeting of small GTPases through 
membrane trafficking events along acetylated tubulin-enriched microtubule tracks, as 
well as the apical membrane targeting of key downstream regulators including Rasip1 
and c-Raf.   
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MATERIALS AND METHODS 
 
Reagents 
Stem cell factor (SCF), stromal cell-derived factor 1 alpha (SDF-1α), and 
interleukin-3 (IL-3) were obtained from R&D systems (Minneapolis, MN).  Tubacin was 
obtained from TOCRIS Bioscience (Bristol, United Kingdom).  Ascorbic acid, 12-O-
tetradecanoyl-phorbol-13-acetate (TPA), and antibodies against Arhgap31, acetylated 
tubulin, α-tubulin, and phospho-C-Raf Tyr341 were obtained from Sigma-Aldrich (St. 
Louis, MO). Recombinant fibroblast growth factor 2 (FGF-2) and antibodies against 
Rac2, detyrosinated tubulin, and β-actin was obtained from EMD Millipore.  Antibodies 
against MRCKβ, k-Ras, Rasip1, GIT1, and MT1-MMP were obtained from Abcam 
(Cambridge, MA). Antibodies against IQGAP1, ROCK1, and Integrin α2 were obtained 
from BD Biosciences (San Jose, CA). Antibodies against Rap1B, α-Pix, β-Pix, Cdc42, 
phospho-p44/42 MAPK (ERK 1/2) Thr202/Tyr204, ERK 1/2, phospho-PAK2 Ser141, 
PAK2, phospho-PAK4 Ser474, PAK4, phospho-B-Raf Thr401, phospho-B-Raf Ser445, 
B-Raf, phospho-C-Raf Ser388, C-Raf, phospho-Src Y416, Src, phospho-p38 MAPK 
Thr180/Tyr182, p38 MAPK, and phospho-Tyr were obtained from Cell Signaling 
Technologies (Danvers, MA). An antibody against Rasa1 was obtained from Epitomics 
(Burlingame, CA). Antibodies against RhoA and Rac1 were obtained from Cytoskeleton 
(Denver, CO). An antibody against Arhgap29 was from Bethyl Laboratories 
(Montgomery, TX).  An antibody against GAPDH was purchased from Research 
Diagnostics Inc (Flanders, NJ). Alexa fluor® 488 and Alexa fluor® 633 antibodies, and 
Alexa fluor® 488 and 633 phalloidin were from Molecular Probes (Eugene, OR).  WT 
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PKCε adenovirus was purchased from Seven Hills Bioreagents (Cincinnati, OH) and WT 
CSK and DN CSK adenoviruses were purchased from Cell Biolabs (San Diego, CA). 
GFP, GFP-Cdc42, GFP-Rac1, GFP-RhoA, GFP-N17Rac1, GFP-N19RhoA, GFP-
N17Cdc42 and GFP-V12Rac1 adenoviruses were generated as previously described 7, as 
well as DN-Pak4 adenovirus 8, and MT1-ΔC WT and MT1-ΔC EA adenoviruses 10,14. 
 
Vasculogenic tube assembly assays 
Human umbilical vein endothelial cells were obtained from Lonza (Walkersville, 
MD) and were cultured (passage 3-6) as described previously 23.  ECs were then 
suspended at 2 x 106 cells/mL in 2.5 mg/mL collagen type I matrices and assays were 
performed as previously described 24, 25.  Briefly, SCF, IL-3, SDF-1α, and FGF-2 were 
added at 200 ng/mL into collagen type I. Cultures were fed with media containing 
reduced serum supplement (RSII), ascorbic acid, and FGF-2 at 40 ng/mL. Cultures were 
allowed to assemble into capillary networks over a period of 0-120 hr when cultures were 
fixed or collected for further processing. Samples were fixed in 2% paraformaldehyde or 
3% glutaraldehyde in PBS. Cultures fixed in paraformaldehyde were then stained for 
fluorescent microscopy imaging, whereas cultures fixed in glutaraldehyde were stained in 
0.1% toluidine blue in 30% methanol. Additionally unfixed collagen gels were lysed to 
examine protein expression at the indicated time points using standard western blotting 
techniques.  Recombinant adenovirus infection of ECs was performed as previously 
described7.  
 
 
	 57	
EC siRNA suppression  
siRNA suppression protocols using the siRNA list below were performed as 
previously described 23.  The cells were allowed to recover for 48 hr and transfection was 
repeated. The cells were then allowed to recover overnight before being harvested for use 
in 3D assays. 
siRNAs from Ambion are as follows:  
Control (AM4637) Silencer Select Negative Control #2 
Cdc42 (s2765) 5’-UGGUGCUGUUGGUAAAACA-3’ 
Rac1 (s11711) 5’-CUACUGUCUUUGACAAUUA-3’ 
Rac2 (s11714) 5’-CCUCUUUUGGAACAACAUA-3’ 
RhoA (s758) 5’-CACAGUGUUUGAGAACUAU-3’ 
k-Ras (s7939) 5’-CUAUGGUCCUAGUAGGAAA-3’ 
Rap1b (s224515) 5’-AGAUUCUUCGAGUUAAAGA-3’ 
Pak2 (s10024) 5’-CAGAGGUGGUUACACGGAA-3’ 
Rasip1 (s29763) 5’-CGAGCUGUUCAAAUCCGAA-3’ 
α-Pix (s16948) 5’-GUAAAAGCCCUAAAACGAU-3’ 
β-Pix (s18122) 5’-CAACGACAGGAAUGACAAU-3’ 
GIT1 (s26306) 5’-CCUUGAUCAUCGACAUUCU-3’ 
Rock1 (s12097) 5’-GGUUAGAACAAGAGGUAAA-3’ 
Arhgap31 (s33202) 5’-GGACAGAUCUCUACAUAGA-3’ 
Rasa1 (s11820) 5’-CAUAGAUCACUAUCGAAAA-3’ 
Arhgap29 (s485) 5’-GACCAAGGCUAAAACGAAU-3’ 
Stealth siRNAs from Invitrogen are as follows: 
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Pak4 (NM_001014834_stealth_749)  
5’-UGCUUGCGCAGGUCCAUCUUCUUGA-3’ 
IQGAP1 (NM_003870_stealth_421) 
5’-GCCUCCACUUUAGACACACUGAUAA-3’ 
MRCKβ (NM_006035_stealth 691) 
5’-UAAAUCACCACCCACAUAGUAAUCC-3’ 
 
Generation of S-epitope tagged Cherry, Cherry-fusion proteins, and AcGFP-Rasip1 
adenoviruses 
Cdc42, Rac1, Rac2, RhoA, k-Ras, and Rap1b were amplified from cDNA 
obtained from Missouri S&T cDNA Resource Center (Rolla, MO) and human Rasip1 and 
PKCε were amplified from cDNA obtained from Open Biosystems (Open Biosystems, 
GE Dharmacon, Lafayette, CO), and standard restriction digest cloning for individual 
GTPases and PKCε into pmCherry-C1 plasmid and Rasip1 into pAcGFP-C1 (Clontech, 
Mountain View, CA) using EcoRI-HF and BamHI-HF, XhoI and BamHI-HF, and EcoRI-
HF and XbaI restriction enzymes respectively (New England Biolabs).  Amplified S-
Cherry, S-Ch-GTPase, S-Ch-PKCε, and AcGFP-Rasip1 constructs were subcloned into 
pShuttle-CMV expression plasmid using NotI-HF, XbaI, XhoI, KpnI-HF and SalI-HF 
restriction enzymes, respectively (New England Biolabs). Recombinant adenoviral 
vectors were then generated 26 and propagated as previously described 7.  The PCR 
primers used are listed below with the upstream first followed by the downstream primer.   
Cdc42 5’AGGAATTCTATGCAGACAATTAAGTGTGTTG-3’  
5’-AGGGATCCTTAGAATATACAGCACTTCCTTTT-3’ 
	 59	
Rac1 5’-AGGAATTCTATGCAGGCCATCAAGTGTGTGGTG-3’ 
5’-AGGGATCCTTACAACAGCAGGCATTTTCTCTTC-3’ 
Rac2 5’-AGGAATTCTATGCAGGCCATCAAGTGTGTGGTG-3’ 
5’AGGGATCCCTAGAGGAGGCTGCAGGCGCGCTTC-3’ 
RhoA 5’-AGGAATTCTATGGCTGCCATCCGGAAGAAACTG-3’ 
5’-AGGGATCCTCACAAGACAAGGCACCCAG-3’ 
k-Ras 5’-AGCTCGAGCTATGACTGAATATAAACTTGTGGTAG-3’ 
5’-AGGGATCCTTACATAATTACACACTTTGTCTTTG-3’ 
Rap1b 5’-AGGAATTCTATGCGTGAGTATAAGCTAGTCG-3’ 
5’-AGGGATCCTTAAAGCAGCTGACATGATGAC-3’ 
Rasip1 5’-AGGAATTCTATGCTGTCTGGTGAACGGAAGGAGG-3’ 
5’-AGGTCGACTCAAGGAGACGTGGCCACGGGAGGCCCATG-3’ 
PKCε 5’- AGCTCGAGCTATGGTAGTGTTCAATGGCCTTC-3' 
5'-AGGGATCCTCAGGGCATCAGGTCTTCACCAAAG-3' 
Primers used for cloning into the pAdCMVShuttle plasmid are as follows.  The first two 
primers (S-Cherry and AcGFP) are upstream primers while the following ones are 
downstream primers. 
S-Cherry 
5’-AGGCGGCCGCACCATGGCAAAAGAAACCGCTGCTGCGAAATTTG 
AACGCCAGCACATGGACTCGATGGTGAGCAAGGGCGAGGAG-3’ 
AcGFP 5’-AGGGTACCACCATGGTGAGCAAGGGCGCCGAGCTGTTCAC-3’ 
Cdc42 5’-AGTCTAGATTAGAATATACAGCACTTCCTTTT-3’ 
Rac1 5’-AGTCTAGATTACAACAGCAGGCATTTTCTCTTC -3’ 
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Rac2 5’-AGTCTAGACTAGAGGAGGCTGCAGGCGCGCTTC-3’ 
RhoA 5’-AGTCTAGATCACAAGACAAGGCACCCAG-3’ 
k-Ras 5’-AGCTCGAGTTACATAATTACACACTTTGTCTTTG-3’ 
Rap1b 5’-AGTCTAGATTAAAGCAGCTGACATGATGAC-3’ 
PKCε 5’-AGTCTAGATCAGGGCATCAGGTCTTCACCAAAG-3' 
Rasip1 5’-AGGTCGACTCAAGGAGACGTGGCCACGGGAGGCCCATG-3’ 
 
EC vasculogenesis pull-down assay 
Pull down assays using S-epitope tagged mCherry GTPase fusion protein 
expressing adenoviruses were performed similarly to that previously described23. EC 
vasculogenesis assays were set up in 3.75 mg/mL collagen type I gels using adenovirus 
infected ECs and extracted at the indicated time points. 3D cultures were placed in lysis 
buffer consisting of 1% Triton X-100, 10 mM Tris-base (pH 7.5), 150 mM NaCl, 1 mM 
DTT and 5 mM MgCl2, or 1 mM MgCl2 and 1 mM CaCl2, Complete EDTA-free protease 
inhibitor cocktail tablets (Roche Diagnostics, Indianapolis, IN), collagenase (150 µg/µL 
high-purity; Sigma-Aldrich), and 100 µM GTPγS (Calbiochem). Lysates were incubated 
in a 37°C water bath for 15 minutes to aid in collagen digestion and were clarified by 
centrifugation at 16,000g for 20 minutes at 4°C. Supernatants were then incubated with 
S-protein agarose beads (Novagen, EMD Millipore, Billerica, MA) equilibrated with 
washing buffer (respective lysis buffer containing 0.1% Triton X-100) for 1 hour at 4°C 
on a rocking plate. Beads were then washed 4 times with washing buffer before bound 
protein was eluted with 1.5X sodium dodecyl sulfate sample buffer containing 7.5% β-
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Mercaptoethanol.  Bound GTPase-associated proteins were detected by western blot 
analysis.  
In vitro culture immunofluorescent staining, microscopic imaging, and analysis  
For analysis of 3D cultures, immunostaining was carried out as previously 
described. Immunostained cultures were imaged using a confocal microscope (Leica TC5 
SP5) connected to a multiphoton system (Leica, Buffalo Grove, IL) using excitation 
wavelengths of 488 nm and 543 nm or 488 nm and 633 nm sequentially. High-resolution 
images were captured using a 63X water immersion objective (NA 1.2) utilizing Leica 
Application Suite (LAS) software. Toluidine blue stained cultures were imaged using 
light microscopy on inverted microscopes (Eclipse TE2000-E; Nikon, Melville, NY with 
Photometrics CoolSNAPHQ2 camera, Tucson, AZ, and Olympus CKX41 with Olympus 
DP70 camera, Center Valley, PA). Photographs were analyzed using Metamorph 
software (Molecular Devices, Sunnyvale, CA) by tracing vessel area and lumen area.  
Time-lapse videomicroscopy was performed using light microscopy and a 20X objective 
with a fluorescent inverted microscope (DMI6000B, Leica) over a 72 hr period. 
 
Immunofluorescent and immunocytochemical staining of embryonic tissues 
Female mice expressing the Rosa26 yellow fluorescent protein (YFP) reporter 
were mated with male mice expressing Cadherin5-CreERT2. Pregnant females were 
induced with tamoxifen (2mg/40g Mouse) at E12 and E13, and then embryos dissected at 
E14. Head dermis positive for YFP was isolated, fixed in 4% PFA/PBS for 1hr at 4oC 
then washed in PBS. Primary antibody incubations were carried out at 4°C O/N (diluted 
1:300 for GFP, 1:100 for Rasip1), slides were washed in PBS, and then incubated in 
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secondary antibody for 4hrs at RT (diluted 1:500). Slides were washed in PBS incubated 
with DAPI and mounted. Images were obtained using a LSM710 Meta Zeiss confocal. 
Antibodies used include: anti-GFP (Aves/ GFP-1020), Rasip1 (Novus Biologicals/ 
NB300-967), and Alexa Fluor 555 donkey anti-goat (Invitrogen/ A21432, Donkey anti-
chicken 488 (Jackson Immuno Cat#703-545-155).  Rasip1+/- and Rasip1-/- embryos were 
fixed in 4% PFA/PBS and stored in 75% ethanol. Embryos were processed and sectioned 
as described.  Sections were incubated with primary antibody (diluted 1:100 PECAM, 
1:100 Endomucin) overnight at 4oC, and after washing, were incubated with Donkey anti-
Rat HRP secondary antibody (diluted 1:100). The DAB reaction was performed using a 
peroxidase substrate kit (Vector).  The slides were imaged using a NeoLumar 
stereomicroscope (Zeiss). Antibodies used include: Goat anti-rat IgG (Santa Cruz/ 
A10549), PECAM (BD Biociences/ 553370), Endomucin (Santa Cruz/ sc-65495).  
 
Statistical analysis 
Statistical analysis was completed using Microsoft Excel. Statistical significance 
was set at minimum with P < 0.05. Student t-tests were used when analyzing two groups 
within individual experiments (with a minimum n = 10). 
 
Ethics Statement 
All animal studies were performed in accordance with UT Southwestern Medical 
Center Institutional Animal Care and Use Committee (IACUC) approved protocol APN 
2008-0310, approval date September 25, 2014.  Mice were euthanized by CO2 
asphyxiation followed by cervical dislocation.   
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RESULTS 
 
Identification of new small GTPase regulators of EC tubulogenesis 
Our laboratory has previously demonstrated a critical role for Cdc42 and Rac1, as 
well as key effectors such as Pak2, Pak4 and the polarity proteins, Par6b and Par3, during 
EC lumen formation 8, 14.  We performed a broader small GTPase screen using siRNA 
suppression where we identified several new regulators as well as effectors of these 
GTPases (Figure 2.1 and see later on).  We are now demonstrating a key role for k-Ras, 
Rac2 and Rap1b during this process (Figure 2.1, Supplemental Figure 2.1).  In contrast, 
siRNA suppression of RhoA had no influence.  We increased expression of these 
GTPases using wild-type proteins that were fused on their N-terminus with mCherry and 
an S-epitope tag (for biochemical pulldown assays).  Increasing expression of Cdc42, k-
Ras, and Rap1b all significantly enhanced EC lumen formation, while others did not 
(Supplemental Figure 2.1).  Using combinations of siRNAs, we demonstrated that 
knockdown of Cdc42 with k-Ras, Rac2, and Rap1b, appear to have the greatest blocking 
influence (Figure 2.1C,D) compared to Cdc42 knockdown alone.  Combined knockdown 
of k-Ras with Rac1, Rac2 or Rap1b did not block in a significant manner compared to k-
Ras alone (not shown). This data suggests that Cdc42-dependent signaling in 
combination with either k-Ras, Rac2 and Rap1b, appears to be necessary for ECs to form 
lumens and tubes in a 3D matrix environment. 
 
Functionally interchangeable Factor- and Phorbol ester-induced human EC lumen and 
tube formation models  
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Our studies have utilized two highly defined and related systems, which have 
allowed us to investigate the human EC lumen formation process.  One of them utilizes 
defined growth factors (Factor-induced model) that drive EC tubulogenesis, while the 
other depends on the addition of phorbol ester 23, 24, 27.  Most of the studies in this report 
utilize the Factor-induced model 24.   To characterize this new system with regard to our 
previous published work using the phorbol ester model and EC lumen formation, we have 
performed detailed Western blots to assess signaling pathways and requirements during 
the tubulogenic process (Figure 2.2).  We previously reported that the phorbol ester 
system required the protein kinase C (PKC) isoform, PKCε and Src kinases as well as a 
downstream cascade leading to Pak2, Pak4, Raf and Erk activation in order to form EC 
lumens and tube networks 9.  Lumen formation in this system also requires the α2β1 
integrin and membrane-type I metalloproteinase (MT1-MMP).  Using the Factor model, 
lumen formation is markedly stimulated by PKCε, dominant negative Csk (to activate Src 
kinases) as well as a cytoplasmic tail deleted wild type MT1-MMP construct (Figure 
2.2C), all of which mimic what we reported in past work 9, 14.  Furthermore, we 
demonstrate that increased expression of Csk, to block Src activation, addition of the Src 
inhibitor, PP2 (but not PP3, its inactive control) (not shown) or expression of a dominant 
negative inhibitor of MT1-MMP (cytoplasmic tail deleted combined with an inactivating 
mutation) all dramatically interfere with lumen formation just like we previously 
observed (Figure 2.2C) 9, 14, suggesting that our two model systems appear to be 
functionally interchangeable.  A final point is that we previously reported that increased 
tubulin acetylation and detyrosination accompany lumen formation and are necessary to 
stabilize the developing EC apical membrane using the phorbol ester model 21.  Here, we 
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show the same increases in tubulin acetylation and detyrosination during lumen 
formation using the Factor system (Figure 2.2), and furthermore, addition of the HDAC6 
inhibitor, tubacin, which strongly increases tubulin acetylation, leads to marked increases 
in lumen formation (Supplementary Figure 2.1). 
 
Differential signaling events during Factor-induced EC lumen and tube formation 
During the time course of lumen formation using the Factors, we observe 
increases in the expression of both α2β1 integrin and MT1-MMP, as well as increased 
phosphorylation of Src, Pak4, B-Raf, c-Raf, and Erk, while levels of p38 Map kinase 
phosphorylation remain low compared to controls (Figure 2.2).  We also performed 
Western blots over time to assess whether changes in proteins that are tyrosine 
phosphorylated are differentially regulated during lumen formation.  We observe 
increased tyrosine phosphorylation of bands during this process at 225, 150, 130, 120, 
100, 78, 68, 60, 45, 40, 36, and 30 kDa (Figure 2.2).  EC tubulogenesis is Src family- and 
receptor tyrosine kinase-dependent through Factor and extracellular matrix signaling 
events and work is ongoing to identify these tyrosine phosphorylated bands that are 
induced during this process.  
 
Small GTPase targeting and polarization to apical membranes and the microtubule 
cytoskeleton enriched in acetylated tubulin during EC lumen formation 
 One of the key steps in lumen formation is creation of a unique apical surface.  
We are putting forth a considerable effort in our laboratory to define how the apical 
surface forms and stabilizes during EC lumen formation.  For example, we recently 
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showed that the modified tubulins, acetylated and detyrosinated tubulin are subapically 
polarized during lumen formation (Figure 2.3) and this depends on the microtubule plus-
end regulators, EB1, p150glued and Clasp1 21.  Blockade of these molecules results in 
interference with lumen formation and apical polarization.  By contrast, F-actin as 
visualized using phalloidin, is polarized in a basal location.  Here, we have imaged the 
subcellular localization of small GTPases (using fluorescent fusion proteins) that directly 
influence this process.  Cdc42, Rac1, Rac2, k-Ras, and Rap1b all show targeting ability 
to the apical surface in comparison to the basal distribution of F-actin (Figure 2.3, 
Supplementary Figure 2.1).  In addition, a key activated effector downstream of these 
GTPases is phospho-c-Raf 9, 14, which also shows apical targeting during these events 
(Supplementary Figure 2.1). 
Furthermore, we have examined the relationship between Cdc42 and Rac1 and the 
appearance of these proteins in the apical domain along with acetylated tubulin, which is 
strongly polarized subapically (Figure 2.3).  Cdc42 concentrates in a subapical 
distribution that also shows focal co-localization with acetylated tubulin (Figure 2.3).  By 
contrast, although acetylated tubulin is subapically distributed, GFP (control) or RhoA do 
not display apical localization.  We also performed experiments by expressing 
constitutively active GFP-V12Rac1 (which enhances lumen formation) 7, which 
stimulated the appearance of acetylated and detyrosinated tubulin and promoted 
localization of acetylated tubulin subapically (Figure 2.3, Supplementary Figure 2.2).  
Expression of dominant negative Cdc42, Rac1, and Pak4 constructs (which block lumen 
formation) 7, 8 reduced acetylated tubulin compared to control or dominant negative 
RhoA expression (Supplementary Figure 2.2).  Using GFP-Rac1, GFP-V12Rac1, GFP-
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Cdc42 constructs versus control GFP or GFP-RhoA constructs, we are able to observe 
pinocytic intracellular vacuoles 7, 27 which traffic apically to fuse along modified tubulin 
cytoskeletal tracks in a subapical and pericentrosomal region to contribute to the EC 
apical luminal membrane over time (Figure 2.3). 
 
Cdc42, Rac, and Ras GAPs, Arhgap31 and Rasa1, inhibit EC lumen formation, while 
RhoGAP, Arhgap29, stimulates this process 
 To address the role of specific GTPases in EC lumen formation using a distinct 
approach, we have identified three GTPase activating proteins (GAPs) (which inactivate 
the GTPases) that control the EC lumen formation process (Figure 2.4).  Arhgap31 shows 
specificity for Cdc42 and Rac 28, Rasa1 for Ras 29, and Arhgap29 for RhoA 11.  Arhgap29 
is a known binding partner of Rasip1, a key regulator of EC lumen formation 11.  siRNA 
suppression of Arhhap31 and Rasa1 (or in combination) strongly stimulated EC lumen 
and tube formation, while suppression of Arhgap29 strongly inhibited (Figure 2.4).  This 
latter result is consistent with previous observations from our laboratory where RhoA 
played a direct role in vessel collapse following microtubule disruption 22.  Increased 
expression of activated RhoA completely inhibited EC lumen formation 7 and 
interestingly, infection of ECs with the microorganism, Bartonella bacilliformis, which 
led to RhoA activation, similarly blocked EC tube formation 30. 
To assess the influence of GAP knockdown on EC signaling during lumen 
formation, we performed Western blots at different time points during the process.  This 
approach allows us to assess the relative contribution of Cdc42/Rac, k-Ras, and RhoA 
toward the signaling pathways that are activated during lumen formation (Figure 2.2, 
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Figure 2.5).  Interestingly, the expression of α2β1 integrin and MT1-MMP were modestly 
increased when Arhgap31 and Rasa1 are suppressed compared to control, and similar 
findings were observed with Pak2.  Erk1/2 levels modestly increased selectively with 
Rasa1 knockdown that accompany stronger increases in Erk1/2 phosphorylation.   We 
observe increased phosphorylation of Pak2 and Pak4 that occur following knockdown of 
either Arhgap31 or Rasa1 (or the combination).  Since Pak4 is a selective effector of 
Cdc42, this result suggests that activation of k-Ras (via Rasa1 knockdown) leads to 
increased activation of Cdc42, demonstrating that these pathways are co-activating each 
other (perhaps through upstream guanine exchange factors- GEFs).  Similar results were 
observed with Pak2 activation where Rasa1 knockdown increases Pak2 phosphorylation, 
an effector of both Cdc42 and Rac1/2.  We also examined tyrosine phosphorylation of 
substrates in these samples and observed that bands at 150, 78, 60, 45, and 36 kDa were 
increased when either Arhgap31 or Rasa1 (or both) were suppressed, while a band at 40 
kDa appeared to be increased more selectively with Rasa1 knockdown.  This data 
suggests that these phosphoproteins may be involved in the lumen formation process 
since their phosphorylation patterns correlate with EC tube formation ability (Figure 2.5) 
and they were also regulated during a time course of tube formation (Figure 2.2).  Future 
work will attempt to identify these proteins and to determine their functions during these 
events. 
 
Identification of new Cdc42, Rac and Ras effectors which control EC tubulogenesis  
Previous work had identified key effectors of Cdc42 and Rac1-dependent EC 
lumen formation and they are, Pak2, Pak4, and Par6b 8.  Par6 binds Par3 which has 
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affinity for the adhesion molecules, JamB, JamC, and VE-cadherin, which we and others 
have shown are critical to EC lumen formation and cell polarity during this process 8, 14, 
16, 19.  Here, we report the identity of new critical effectors in this lumen formation 
process and they are IQGAP1, MRCKβ, Rasip1, GIT1 (a Pak2-binding protein), and β-
Pix, a known Cdc42 and Rac effector, but also a GEF for these GTPases (Figure 2.6, 
Supplementary Figures 2.2, 2.3).  No effects were observed from siRNA suppression of 
α-Pix (which shows modest inhibitory activity) and Rock1, a known RhoA effector 
(Figure 2.6, Supplementary Figure 2.3). 
To address if we could observe additive or synergistic effects of knockdown of 
multiple effectors, we performed combination experiments with more than one siRNA 
(Supplementary Figures 2.2, 2.3).  We also predicted that this type of analysis might 
facilitate our ability to delineate if these effectors were in the same or distinct signaling 
pathways affecting different steps in the EC lumen formation cascade.  The greatest 
blocking combination of siRNAs is when ECs are treated with Pak2 and Pak4, suggesting 
their critical involvement and their likely participation in different steps of the process 
because of the strong additivity or possible synergism (Supplementary Figures 2.2, 2.3).  
Interestingly, both Pak2 and Pak4 siRNAs also additively block with siRNAs to MRCKβ, 
Rasip1 and β-Pix, while Pak2 more selectively added to the blocking effects of IQGAP1 
siRNA (Supplementary Figure 2.2).  Additive blocking effects were observed with 
Rasip1 with Pak2, Pak4, IQGAP1 and MRCKβ siRNAs, but not with β-Pix, suggesting 
the possibility that they are functionally linked in a signaling pathway.  Additive blocking 
effects were seen with MRCKβ combined with Pak2, Pak4, Rasip1, but not with either 
IQGAP1 or β-Pix.  Finally, IQGAP1 siRNA showed additive blocking effects with Pak2 
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and Rasip1, and β-Pix siRNA induced additive blocking effects when combined with 
either Pak2 or Pak4, but not the other effectors.  A key point is that these molecules 
represent critical effectors of lumen formation which are directly linked to Cdc42-, Rac1-
, Rac2-, and k-Ras-dependent signaling and when we suppress the expression of these in 
combination (Supplementary Figure 2.2), there is a profound interference in the ability of 
ECs to form tubes. 
 
EC tubulogenesis is controlled by Rasip1 in vitro and in vivo, and Rasip1 localizes to the 
EC apical membrane during lumen formation  
Previous work demonstrated a role for Rasip1 in EC lumen formation in vivo and 
in vitro 11.  Here, we extend these studies to show that using our new Factor system, 
Rasip1 siRNA treatment reveals a phenotype that directly recapitulates what we observe 
in vivo in the Rasip1 knockout animals (Figure 2.6).  EC cords are observed to form and 
that reach their appropriate locations in the embryo, but they fail to lumenize (Figure 
2.6C).  We observe this exact phenotype in that they effectively assemble into cords in a 
pattern that resembles that of the control siRNA culture, but they fail to form lumens 
(Figure 2.6C).  Thus, the in vivo knockout data is clearly reflected in the in vitro assays 
which show the same morphogenic phenotype.  Our key findings using in vitro models of 
EC lumen formation and EC-pericyte tube co-assembly have repeatedly been 
demonstrated to be recapitulated in multiple species including Zebrafish, quail and mice.    
To assess further a possible role for Rasip1 during these events, we constructed a 
vector carrying GFP-Rasip1 and transduced it into ECs and performed lumen formation 
assays.  In addition, we increased PKCε expression which enhanced targeting of GFP-
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Rasip1 to the EC apical surface during lumen formation (Figure 2.6D).  We also co-
expressed GFP-Rasip1 with other mCherry control or GTPase fusion proteins and in all 
cases Rasip1 is observed to target apical surfaces during lumen formation over time 
(Figure 2.6E).  In addition, immunofluorescence staining in vivo during mouse vascular 
development shows a similar distribution of Rasip1 which is observed more selectively 
along the EC apical surface during initiation of lumen opening (Figure 2.6D).  This novel 
data suggests that Rasip1 can target the EC apical surface and this ability correlates with 
its ability to control lumen formation like the apical/subapical targeting of the key small 
GTPases (Figure 2.3, Supplementary Figure 2.1).  Overall, our findings suggest that 
membrane transfer events from basal to apical are likely to underlie the molecular 
mechanisms that control the development and expansion of the EC apical membrane 
surface during lumen and tube formation. 
 
Real-time video analysis reveals critical involvement of key GTPases, GAPs, and 
effectors during EC tubulogenesis   
 Another experimental approach that we have taken previously and also here is to 
perform real-time video analysis of EC tubulogenic responses of control vs. siRNA 
treated ECs.  Control siRNA-treated cells form extensive networks of tubes over the 72 
hr time period.  During the first 12 hr and later on also, vesicular trafficking and 
intracellular vacuole formation is observed which contributes to the lumen formation 
process (Video S1) and is demonstrated in our confocal imaging shown earlier (Figure 
2.3).  siRNA suppression of Cdc42 markedly interferes with EC tubulogenesis (Video 
S2).  Interestingly, it appears that the ECs with reduced Cdc42 are attempting to form 
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lumens and tubes, but then they collapse.  In contrast, siRNA suppression of RhoA in 
ECs allows them to form lumens and tubes just like the control siRNA-treated ECs 
(Video S3).  siRNA suppression of Arhgap31 (Video S4) and Rasa1 (Video S5) which 
activates Cdc42, Rac1 and k-Ras, respectively, leads to an acceleration of lumen and tube 
formation.  In contrast, siRNA knockdown of Arhgap29, leading to activation of RhoA, 
leads to inhibition of EC tubulogenesis, where EC cord formation occurs, and attempts at 
tube formation are observed, but this is followed by collapse of the developing luminal 
space (Video S6).  Very similar findings are observed with Rasip1 siRNA-treated ECs, 
where EC cord assembly occurs, but lumen formation does not (Video S7).  Combined 
siRNA suppression of key lumen regulators including Cdc42 and k-Ras (Video S8), 
Cdc42 and Rac2 (Video S9), and Cdc42 and Rap1b (Video S10), reveal marked blockade 
of EC tubulogenesis. 
 
Differential interactions of small GTPases with downstream effectors as well as MT1-
MMP and α2β1 integrin during EC lumen formation  
To further address the functional biochemical connections of the GTPases and 
effectors in the EC lumen formation cascade, we performed pull-down assays using our 
S-Cherry GTPases constructs during this process in 3D matrices.  We also stimulated 
lumen formation by increasing the expression of PKCε in order to assess if the pulldown 
assays correlate with the functional enhancement of lumen formation (Figure 2.7) (see 
Figure 2.2C).  Consistently in our pulldown experiments, S-Ch-Rac2 and S-Ch-k-Ras 
strongly co-precipitate with MT1-MMP, but not S-Cherry control.  These pulldowns 
were enhanced by increased expression of PKCε.  Similar results were observed with 
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α2β1 pulldown and this is consistent with our previous observations demonstrating an 
interaction between MT1-MMP and α2β1 integrin 14.  This demonstrates that two key 
regulators of lumen formation, MT1-MMP and α2β1, also interact in multiprotein 
complexes with key small GTPases controlling lumen formation, namely Rac2 and k-
Ras, and this is stimulated by increased PKCε expression.  Lesser but detectable 
interactions were also observed with Cdc42 and Rac1, but not Cherry control.  IQGAP1 
strongly interacts with Cdc42 and also to a lesser extent with Rac1 (Figure 2.7A), but not 
the other proteins and these interactions increase as lumen formation proceeds (Figure 
2.7B).  MRCKβ interacts selectively with Cdc42 during the lumen formation process and 
this interaction is enhanced by increased PKCε expression (Figure 2.7A).  Interestingly, 
MRCKβ is activated by diacylglycerol, like PKCε.  Finally, we performed these 
experiments and blotted for phosphotyrosine-containing proteins and identified unique 
interactions for the different GTPases (Figure 2.7).  k-Ras interacts with two 
phosphotyrosine-containing proteins at 42 and 34 kDa, while Rac1 and Rac2 interact 
with a band at 40 kDa and Cdc42 binds to a 45 kDa band (Figure 2.7A).  The identity of 
each of these bands will be pursued in future studies.  When PKCε expression is 
enhanced, each of these bands increases their respective GTPase association.  This data 
indicates unique associations of each GTPase during EC lumen formation. 
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DISCUSSION 
 
A critical question in vascular biology is how ECs assemble networks of tubes 
with defined lumens 2-5.  A primary function of ECs is to undergo tubulogenesis, maintain 
tube structures, and then specialize into ECs with unique functions tailored to meet 
specific tissue requirements.  Here, we focused on the molecular mechanisms underlying 
EC lumen and tube assembly.   We identify new GTPase regulators of EC lumen 
formation as well as downstream regulators of these GTPases.  In addition to reaffirming 
a key role for Cdc42, Rac1 and their effectors, Pak2 and Pak4, we demonstrate novel 
roles for Rac2, k-Ras, Rap1b, and the effectors, IQGAP1, MRCKβ, β-Pix, GIT1 and 
Rasip1.  Furthermore, we demonstrate important new roles for three GAPs: Arhgap31 
which inactivates Cdc42 and Rac, Rasa1 which inactivates k-Ras, and Arhgap29 which 
inactivates RhoA.  Arhgap31 and Rasa1 siRNAs were shown individually and in 
combination to stimulate tube formation (via blockade of Cdc42, Rac, and Ras 
respectively), while Arhgap29 siRNA inhibits tube formation (via blockade of RhoA).  
The above molecules appear to control EC tubulogenesis by affecting asymmetric 
cytoskeletal polarization (i.e. modified tubulins expressed subapically, F-actin basally), 
which is necessary to direct membrane trafficking events toward the new apical surface 
to create a defined lumen in a 3D environment.  Furthermore, we demonstrate that 
Cdc42, Rac, k-Ras, Rasip1, and phospho-c-Raf accumulate at the developing apical 
membrane, while acetylated tubulin is strongly localized subapically to support this 
apical surface.  Interestingly, in focal regions within this subapical domain, there is strong 
co-localization of Cdc42 with acetylated tubulin.   
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A key conclusion of our findings is that small GTPase-mediated signaling in 
conjunction with a kinase signaling cascade involving PKCε, Src, Pak, Raf and Erk 
kinases leads to three major events that control EC tubulogenesis (Figure 2.8).  The first 
is the establishment of asymmetric cytoskeletal polarity with subapical modified tubulins 
(particularly acetylated tubulin, but also detyrosinated tubulin), and F-actin distributed in 
a strong basal location.  Our data suggests that this is necessary to direct membrane 
trafficking along subapically polarized microtubule tracks, which appears to facilitate 
focal apical accumulation of vesicles/ vacuoles and subsequent vesicle fusion events to 
create the luminal space.  The membranes that become the apical membrane surface are 
clearly enriched in small GTPases that affect EC lumen and tube formation including 
those that we evaluate here: Cdc42, Rac1, Rac2, k-Ras, and Rap1b.  The second process 
is the creation of a polarized apical membrane surface.  Vesicle/vacuole trafficking to this 
apical membrane appears to occur along the microtubule cytoskeleton and they 
accumulate in a pericentrosomal and perinuclear region.  Thirdly, vesicle-to-vesicle 
fusion events (from vesicles derived from pinocytosed/ endocytosed membranes or other 
intracellular membranes derived from endoplasmic reticulum, Golgi or Weibel-Palade 
bodies) occur to generate an apical membrane template, which can then be further 
remodeled over time through endocytic and exocytic membrane trafficking events to 
develop a mature EC apical membrane domain.  The molecular composition of this EC 
apical membrane domain is not well understood and ongoing work is addressing how it is 
assembled and maintained.  Published real-time videos from our laboratory have revealed 
the dynamic nature of these membrane trafficking and vesicle fusion events which occur 
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rapidly over a 4-72 hr period to create networks of capillary tubes with defined lumens 2, 
10, 11, 31, 32. 
Our new work demonstrates that multiple small GTPases contribute to EC tube 
formation, and we chose to focus our attention on Cdc42, Rac1, Rac2, k-Ras and Rap1b.  
siRNA suppression of Cdc42 in combination with k-Ras, Rac2 and Rap1b resulted in the 
most profound blocking effects, while blockade of Pak2 (activated by both Cdc42 and 
Rac isoforms) combined with multiple other effectors resulted in similar very strong 
blocking effects.  Similar marked blocking effects were observed with Rasip1 siRNA 
suppression combined with either IQGAP1 or MRCKβ, which are Ras, Rac and Cdc42 
effectors 33-36.  This is highly supportive again of the conclusion that multiple GTPases 
and effectors work in concert to control this process.  This is also demonstrated by siRNA 
suppression of Arhgap31 and Rasa1 together (to stimulate Cdc42, Rac and Ras activity in 
combination), where marked stimulation of EC tube formation occurs.  Interestingly, 
other work supports our general conclusions, in that IQGAP1 is known to directly 
interact with k-Ras, b-Raf, and Erk 33, 37, 38; thus serving as a scaffolding protein to 
promote Erk activity downstream of Cdc42 and Rac activation.  In addition, Cdc42 and 
MRCKβ have been implicated in nuclear positioning in conjunction with centrosome 
reorientation during cell motility events 39, and this process may also be critical during 
EC lumen formation since we observe accumulation of vesicles/vacuoles in a polarized 
pericentrosomal/perinuclear region.  Src activity has been reported to inhibit the 
Rho/Rock pathway 40, a pathway also inhibited by Pak2/Pak4 41 and Rasip1/Arhgap29 11.  
Interestingly, Rap1 is known to affect the function of Rasip1/Arhgap29 42.  In addition, 
Src activation blocks the activity of Rasa1 43, while stimulating Pak2/Pak4 activation and 
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Raf activation 9.  Interestingly, the Cdc42 guanine exchange factor (GEF), intersectin1, 
has been reported to inhibit the activity of Arhgap31 44.  Future work in our laboratory 
will focus on the identification of the relevant GEFs which activate the key small 
GTPases that we have identified to control EC lumen and tube formation. 
A major regulator of EC tubulogenesis is membrane trafficking from basal to 
apical, but possibly also from other intracellular membranes to the apical surface.  In one 
of our first studies we demonstrated the presence of von Willebrand factor present inside 
intracellular vacuoles suggesting potential fusion of Weibel-Palade bodies with these 
vacuoles 27.  We observe the presence of intracellular vacuoles which are 
macropinosome-like structures (the vacuoles are strongly labeled by including membrane 
impermeant fluorescent dyes into the culture media showing that they are pinocytic) that 
are transported toward the apical surface to fuse with the luminal membrane 27.  These 
vacuole membranes can clearly be shown to possess Rac1 (very strongly observed when 
constitutively active Rac is utilized) suggesting that active Rac targets these membranes.  
Cdc42 appears to surround these structures in vitro and in vivo (when GFP-Cdc42 was 
expressed in ECs in Zebrafish embryos) 7, 31, 45 and can be observed to accumulate 
subapically along with acetylated tubulin where focal areas of strong co-localization can 
be seen.  These are also regions of probable vacuole-vacuole and vacuole-apical 
membrane fusion events that control the creation of the polarized luminal surface.  Our 
new work suggests that Rasip1 can target apically and this is observed to a greater extent 
when we increase the expression of PKCε, a stimulus that markedly accelerates EC 
lumen and tube formation.  Past work suggests that Ras can interact with Rasip1, so there 
may be a direct relationship with these findings, more studies will need to investigate 
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these potential connections.  Also, further work will need to address the role of different 
membrane compartments (basal to apical transfer through intracellular vacuoles) or other 
intracellular membranes (vesicle trafficking from endoplasmic reticulum or Golgi, or 
trafficking from structures such as Weibel-Palade bodies), and determine how individual 
proteins such as Rasip1 and Rac1 target to the apical surface. 
One of the intriguing questions in cell biology is what are the necessary molecules 
and signals that are required for cells to generate lumens and tubes and what distinguishes 
them from cells that cannot.  ECs and many types of epithelial cells can form tube 
structures, while cell types such as fibroblasts, pericytes, and vascular smooth muscle 
cells cannot.  Of great interest is that we have identified a key series of molecules and 
signals that are necessary for ECs to form lumens and tubes.  Genetic or chemical 
blockade of these molecules and signals converts ECs into cells that lose this ability to 
form lumens.  We also presented data showing inhibitory roles for the GAPs Rasa1 and 
Arhgap31, and the lumen formation signaling cascade may function in part to suppresses 
their activity.  Furthermore, previous work has suggested that EC lumen signaling 
suppresses RhoA- and Rock-dependent signaling and key EC molecules such as Rasip1, 
Arhgap29, CCM proteins, Src, Pak2 and Pak4 are known to suppress Rho/Rock 
activation 3, 4.  In addition, our previous work has identified other inhibitors of EC lumen 
formation including HDAC6, Sirt2, Csk, TIMP2 and TIMP3 9, 21, 32.  It is becoming 
increasing clear that EC tube formation is controlled by a balance of stimulatory and 
inhibitory molecules (Figure 2.8).   Vessel abnormalities could result from imbalances of 
signals from either one of these sets of molecules.  How such a balance controls the 
ability of ECs to form tubes and other cells such as fibroblasts to not form tubes is a key 
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cell biological problem and question that needs to be investigated in detail in future 
studies.  
In addition to our efforts to elucidate how ECs form lumens and tubes in 3D 
matrices, we have previously investigated another key way in which ECs within 
capillaries become polarized and that is the selective recruitment of pericytes to the EC 
abluminal surface 20, 46, 47.  Of great interest, pericyte recruitment to EC-lined tubes in 
capillaries leads to another critical event which is the abluminal and, thus, polarized 
deposition of the vascular basement membrane, a process that requires both cell types 46-
48.  An important question for future studies is how the tubulogenic regulators that we 
describe impact the ability of EC cord and tube networks to attract pericytes and induce 
vascular basement membrane assembly.  Thus, the tubulogenic mechanism that we 
describe here is an essential and fundamental step in EC polarity and vessel maturation, 
which is further amplified by the recruitment and retention of pericytes around capillary 
tubes.  
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FIGURES AND LEGENDS 
 
FIGURE 2.1 
 
 
 
Figure 2.1.  Identification of key small GTPases that control EC tubulogenesis in 3D 
matrices.  (A) Individual EC cultures were transfected with control siRNA or with 
siRNAs directed to Cdc42, Rac1, Rac2, RhoA, k-Ras, and Rap1b, and then were 
suspended in 3D collagen matrices for 72 hr. Data are reported as the mean total vessel 
area per high-power field (HPF) ± standard deviation (SD) (n = 15, p < 0.01).  Asterisk 
indicates significance compared to control cultures. Fixed cultures were fixed, stained 
and photographed.  Bar equals 100 µm (B).  (B) Lysates generated from siRNA 
transfected cultures in (A) were used in Western blots to assess specific protein 
knockdown versus control.  (C,D) Individual EC cultures were transfected with siRNA 
targeting Cdc42, combinations of Cdc42 with Rac1, Rac2, k-Ras, and Rap1B siRNAs, or 
a control siRNA.  EC tubulogenesis assays were performed with the cells and after 72 hr, 
cultures were fixed, photographed (D) and quantitated (C).   Data are reported as the 
mean vessel area ± SD (n=15; p < 0.01). Asterisk indicates significance compared to 
control while the square indicates significance compared to Cdc42 siRNA treatment.  Bar 
equals 100 µm. 
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FIGURE 2.2 
 
 
 
Figure 2.2. Signaling events that characterize EC tubulogenesis over time in 3D collagen 
matrices. (A) ECs suspended in 3D collagen matrices were lysed at the indicated time 
points for Western Blot analysis to assess expression and signaling of the indicated 
molecules or were fixed and photographed while ECs are assembling into tubes over 
time. Representative blots are shown of 1 of 2 experiments.  Bar equals 100 µm.  (B) The 
same time courses were analyzed for phosphotyrosine (pTyr)-containing proteins and 
increased levels of pTyr bands at 225, 150, 130, 120, 100, 76, 68, 60, 45, 40, 36, and 30 
kDa were identified over time correlating with the EC tubulogenic process.  (C) ECs 
were infected with the indicated recombinant adenoviruses and then a lumen assay was 
performed over 72 hr.  Upper panel- ECs were infected with mCherry or PKCe 
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adenoviruses, then cultured in 3D collagen gels, fixed and photographed.  Bar equals 100 
µm.  Lower panel- ECs were infected with adenoviruses carrying GFP, Csk, DN Csk, 
PKCε, tail-deleted catalytically active WT MT1-MMP (MT1-ΔCT wt) or a dominant 
negative MT1-MMP construct (MT1-ΔCT EA), then suspended in 3D collagen matrices 
to assess their ability to form lumens. Data are reported as the mean vessel area ± SD per 
HPF (n=12; p < 0.01).  Asterisks indicate significance compared to control GFP cultures. 
 
FIGURE 2.3 
 
 
 
Figure 2.3. Apical polarization of Cdc42, Rac1 and acetylated tubulin during EC 
tubulogenesis:  Membrane trafficking of vacuoles along microtubule tracks toward the 
apical surface directs EC lumen formation in 3D matrices.  (A) ECs were infected with 
recombinant adenoviruses carrying GFP-Cdc42, GFP-Rac1, GFP-RhoA, or GFP and 
were allowed to form vacuoles and lumens in 3D collagen matrices for 12-16 hr. to 
visualize early events in this process.  Fixed cultures were then immunostained for 
acetylated tubulin, analyzed by confocal microscopy, and representative images are 
shown. White arrowheads indicate subapically polarized acetylated tubulin staining, 
black arrowheads indicate vacuoles (v).  White arrow indicates co-localization of Cdc42 
with acetylated tubulin expression in a polarized subapical domain.  Vacuoles appear to 
be in contact with tubulin cytoskeletal tracks that are enriched in acetylated tubulin that 
coordinate vacuole transport and fusion events at the EC apical membrane surface.  L 
indicates the EC lumen space.  Bar equals 25 µm. (B) ECs were infected with 
recombinant adenoviruses carrying GFP-Rac1, GFP-V12Rac1, or GFP control and after 
12 (upper two panels) or 16 hr. (lower three panels), cultures were fixed and stained with 
either anti-acetylated tubulin antibodies or with phalloidin to label F-actin.  White 
arrowheads indicate apical polarization of acetylated tubulin and v indicates vacuoles.  L 
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indicates lumen space and the white arrow indicates basal polarization of F-actin.   Bar 
equals 25 µm.  
 
FIGURE 2.4 
 
 
 
Figure 2.4. EC tubulogenesis is negatively regulated by the GAPs, Arhgap31 and Rasa1, 
and is positively regulated by Arhgap29. Individual EC cultures were transfected with a 
control siRNA or siRNAs directed to Arhgap31, Rasa1, Arhgap29, or the combination of 
Arhgap31 and Rasa1.  Treated ECs were then suspended in 3D collagen matrices for 72 
hr, were fixed, photographed and lumen formation was quantitated. (A) Representative 
images of control, Arhgap31, Rasa1, Arhgap31 and Rasa1, and Arhgap29 siRNA 
transfected EC 3D cultures are shown.  Bar equals 100 µm. (B) Cultures from (A) were 
quantified for EC tube formation (B). Data are reported as mean vessel area ± SD per 
HPF (n = 10; p < 0.01). Asterisk indicates significance compared to control. (C) ECs 
were treated with the indicated control or GAP siRNAs, lumen assays were performed, 
fixed, and quantitated at the indicated time points.  Squares indicate significance at p<.01 
above control while asterisks indicate significance below control (n=10).  (D) siRNA 
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transfected EC lysates were examined for the degree of protein knockdown using 
Western Blot analysis. 
 
FIGURE 2.5 
 
 
 
Figure 2.5. Increased Cdc42, Rac, and Ras activity via siRNA suppression of Arhgap31, 
Rasa1 or both stimulates key signaling pathways and molecules that control EC 
tubulogenesis.  Individual EC cultures were transfected with control siRNA or siRNA 
targeted against Arhgap31, Rasa1, Arhgap31 and Rasa1, or Arhgap29 and suspended in 
3D collagen gel matrices.  Lysates were generated at the indicated time points (24, 48, 
and 72 hr) from 3D cultures for Western Blot analysis to assess the expression of α2 
integrin, MT1-MMP, p-Pak2, Pak2, p-Pak4, Pak4, p-Erk, Erk, acetylated tubulin, 
detyrosinated tubulin, tyrosine phosphorylated proteins, and actin over time. 
Representative blots are shown of 1 of 2 experiments.  
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FIGURE 2.6 
 
 
 
Figure 2.6. IQGAP1, MRCKβ, Rasip1, and beta-Pix are critical downstream effectors of 
small GTPase signaling that control EC tubulogenesis: Rasip1 controls EC tubulogenesis 
in vivo during mouse development and targets to the EC apical surface in vitro and in 
vivo. (A) Individual EC cultures were transfected with a control siRNA or siRNAs that 
are directed to the indicated molecules and were then suspended in 3D collagen matrices 
for 72 hr.  Data are reported as mean vessel area ± SD per HPF (n=10; p < 0.01).  
Asterisk indicates significance below control while square indicates significance above 
control. (B) Lysates generated from siRNA transfected cultures in (A) were used in 
Western Blot analysis and probed for the indicated molecules compared to tubulin 
controls to assess siRNA suppression. (C) Left panels- Wild type vs. Rasip1 knockout 
mice were cross-sectioned at E8 and were stained with CD31 antibodies.  Vascular 
lumens (L) are observed in the wild type but not the knockout mice.  Bar equals 500 µm.  
Right panels- ECs were treated with control vs. Rasip1 siRNAs, were seeded in 3D 
collagen matrices, and after 72 hr, were fixed, stained and photographed.  Black arrows 
indicate EC tubes with lumens, while white arrowheads indicate EC cords without 
lumens mimicking the in vivo observations seen in the left panels.  Bar equals 100 µm.  
(D) Rasip1 is shown to target to the EC apical surface during tubulogenesis in vitro vs. in 
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vivo.  Upper panel- ECs were infected with adenoviruses carrying GFP-Rasip1 and 
PKCε, were cultured in 3D matrices and after 24 hr, cultures were fixed, and stained with 
phalloidin.  Arrowheads indicate apical labeled of Rasip1, while the arrows indicate basal 
labeling of F-actin.  Bar equals 25 µm.  Lower panel- Immunofluorescent staining of 
Rasip1 in developing mouse vessels demonstrates apical targeting of Rasip1.  
Arrowheads indicate apical staining of Rasip1 (also labeled A), while the arrow indicates 
a basal region without staining (also labeled B).  Bar equals 5 µm.  (E) ECs were induced 
to express GFP-Rasip1, mCherry (Ch), Ch-Cdc42, and Ch-k-Ras, allowed to undergo 
lumen formation, then fixed at the indicated times and imaged by confocal microscopy.  
Arrows indicate apical and sub-apical targeting of Rasip1 during different stages of EC 
lumen formation.  Bars equal 20 µm. 
 
FIGURE 2.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7. Cdc42, Rac1, Rac2, and k-Ras co-associate with α2 integrin, MT1-MMP and 
key GTPase effectors in lumen signaling complexes during EC tubulogenesis in 3D 
collagen matrices.  (A) ECs were induced to express S-Cherry, S-Ch-Cdc42, S-Ch-Rac1, 
S-Ch-Rac2, S-Ch-k-Ras, and with or without PKCε.  Cultures were then suspended in 3D 
collagen matrices for 16 hours, detergent lysates from these cultures were then prepared 
and incubated with S-protein agarose to selectively bind S-epitope tagged proteins and 
their associated proteins.  Eluates were evaluated using Western blot analysis and probed 
for expression of α2 integrin, MT1-MMP, IQGAP1, MRCKβ, and tyrosine 
phosphorylated proteins. (B) EC cultures were induced to express S-Cherry, S-Ch-Cdc42, 
S-Ch-Rac1, S-Ch-Rac2, S-Ch-k-Ras, and S-Ch-Rap1B.  Cultures were then suspended in 
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3D collagen matrices and detergent lysates were prepared at 0, 4, 8, and 16 hr.  Lysates 
were incubated with S-protein agarose and eluates were examined for expression of 
IQGAP1. 
 
FIGURE 2.8 
 
 
 
Figure 2.8. EC tubulogenesis in 3D collagen matrices is controlled by activation of a 
Cdc42-, Rac-, and k-Ras-dependent signaling cascade:  A process that is antagonized by 
Arhgap31, Rasa1 and RhoA.  A schematic diagram is shown illustrating key molecules 
and signals that underlie how ECs form lumens and tubes in 3D collagen matrices.  The 
indicated molecules and signals allow ECs to form tube networks in 3D matrices and 
become polarized with respect to the cytoskeleton (acetylated and detyrosinated tubulin- 
apical; F-actin- basal), and the apical membrane which is decorated with key small 
GTPases that control these processes including Cdc42, Rac1, Rac2, k-Ras and Rap1b. 
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SUPPLEMENTAL FIGURES 
 
SUPPLEMENTAL FIGURE 2.1 
 
 
 
Supplemental Figure 2.1. Apical Polarization of small GTPases and effectors that 
control EC tubulogenesis.  ECs were induced to express Cherry control, the indicated 
Cherry-GTPases or GFP-Cdc42 fusion proteins and lumen formation assays were 
performed for 24 hrs.  (A,B) Confocal images reveal apical targeting of the indicated 
GTPases (arrowheads), and arrows indicate basal targeting of F-actin.  Bar equals 25 µm. 
(C) Apical targeting of activated c-Raf during EC lumen formation (arrows) compared to 
basal targeting of F-actin (arrowheads).  Bar equals 50 µm.  (D) Increased expression of 
Cdc42, k-Ras and Rap1b leads to accelerated lumen formation.  (E) The HDAC6 
inhibitor, Tubacin, stimulates EC lumen formation.  Asterisks indicates significance at 
p<.01 compared to control (n=12).   
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SUPPLEMENTAL FIGURE 2.2 
 
 
 
Supplemental Figure 2.2. Cdc42- and Rac-dependent signaling affect tubulin 
modifications that control EC lumen formation and apical polarization:  Key role of 
small GTPase effectors during EC tubulogenesis.  (A) Left panel- ECs were induced to 
express the indicated dominant negative mutants and lumen cultures were lysed and 
probed with acetylated tubulin vs. control antibodies.  Right panel- ECs were induced to 
express the indicated wild-type proteins or constitutively active Rac1 mutant and lumen 
cultures were lysed and probed with acetylated tubulin, detyrosinated tubulin or control 
antibodies.  (B) ECs were treated with the indicated siRNAs, singly or in combinations of 
two, and EC lumen assays were performed, fixed, photographed and quantitated.  Squares 
indicate significance at p<.01 compared to control, while asterisks indicate significance at 
p<.01 compared to the indicated single siRNA (n=10).  (C) siRNA suppression of GIT1 
reveals a role in EC tubulogenesis.  Asterisk indicates significance at p<.01 compared to 
control.  Bar equals 100 mm.   
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SUPPLEMENTAL FIGURE 2.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 2.3. Small GTPase effectors are fundamental regulators of EC 
tubulogenesis in 3D matrices.  ECs were treated with the indicated siRNAs singly (A) or 
in combination (B) and tube forming assays were performed and fixed after 72 hr.  
Representative photographs of the cultures are shown.  Bar equals 50 µm for A and 100 
µm for B. 
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SUPPLEMENTAL VIDEO LEGENDS 
 
Video S1.  ECs were treated with control siRNA and were allowed to form networks of 
tubes in 3D collagen matrices over 72 hr and in response to the Factors under serum-free 
media conditions.  Considerable movement of the ECs is observed, with intracellular 
vacuolation and membrane trafficking events controlling the lumen formation process.  
ECs assemble together through motility towards each other leading to multicellular EC 
tubes with defined lumens.  The video is shown at 7.7 frames/sec. 
Video S2.  ECs were treated with a Cdc42 siRNA and were suspended in 3D collagen 
over 72 hr and in response to the Factors under serum-free media conditions.  ECs show 
motility and move towards each other leading to some cell-cell clusters, but they fail to 
form sustained lumens and tubes.  There are attempts by the cells to form lumen 
structures but they are unable to sustain them.  The video is shown at 7.7 frames/sec. 
Video S3.  ECs were treated with a RhoA siRNA and were suspended in 3D collagen 
over 72 hr and in response to the Factors under serum-free media conditions.  The treated 
ECs are readily observed to form lumen and tube structures in a manner similar to control 
siRNA-treated ECs.  The video is shown at 7.7 frames/sec. 
Video S4.  ECs were treated with an Arhgap31 siRNA and were suspended in 3D 
collagen over 72 hr and in response to the Factors under serum-free media conditions.  
The treated ECs are readily observed to form lumen and tube structures in an accelerated 
manner due to increased Cdc42 and Rac activity compared to control siRNA-treated ECs.  
The video is shown at 7.7 frames/sec. 
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Video S5.  ECs were treated with a Rasa1 siRNA and were suspended in 3D collagen 
over 72 hr and in response to the Factors under serum-free media conditions.  The treated 
ECs are readily observed to form lumen and tube structures in a markedly accelerated 
manner due to increased Ras activity compared to control siRNA-treated ECs.  The video 
is shown at 7.7 frames/sec. 
Video S6.  ECs were treated with an Arhgap29 siRNA and were suspended in 3D 
collagen over 72 hr and in response to the Factors under serum-free media conditions.  
The treated ECs show the ability to form cords and co-assemble, but attempts at lumen 
and tube formation are rapidly followed by apparent tube collapse secondary to increased 
RhoA activity compared to control siRNA-treated ECs.  The video is shown at 7.7 
frames/sec. 
Video S7.  ECs were treated with a Rasip1 siRNA and were suspended in 3D collagen 
over 72 hr and in response to the Factors under serum-free media conditions.  The treated 
ECs show a strong ability to form cords, like we see in in vivo mouse knockout animals, 
and co-assemble with other ECs.  Apparent attempts at lumen formation are rapidly 
collapsed leaving only networks of cords with no defined lumen space.  The video is 
shown at 7.7 frames/sec. 
Video S8.  ECs were treated with both Cdc42 and k-Ras siRNAs and were suspended in 
3D collagen over 72 hr and in response to the Factors under serum-free media conditions.  
ECs show reduced motility and some EC-EC interactions, but no lumen and tube 
formation, so this combination of siRNAs markedly blocks these processes.  The video is 
shown at 7.7 frames/sec.   
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Video S9.  ECs were treated with both Cdc42 and Rac2 siRNAs and were suspended in 
3D collagen over 72 hr and in response to the Factors under serum-free media conditions.  
ECs show motility, some EC-EC interactions, some interacting cells are seen to come 
apart, but overall, there is no lumen and tube formation observed.  The video is shown at 
7.7 frames/sec.   
Video S10.  ECs were treated with both Cdc42 and Rap1b siRNAs and were suspended 
in 3D collagen over 72 hr and in response to the Factors under serum-free media 
conditions.  ECs show motility, reduced EC-EC interactions, and interacting ECs appear 
to disassemble are seen to come apart, but overall, there is no lumen and tube formation 
observed.  The video is shown at 7.7 frames/sec.           
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CHAPTER III 
 
 
RAB AND RAL GTPASES CONTROL ENDOTHELIAL CELL 
TUBULOGENESIS DURING POLARIZED TRAFFICKING AND 
FUSION OF CAVEOLIN-1-LABELED PINOCYTIC VACUOLES TO 
GENERATE THE APICAL MEMBRANE SURFACE 
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ABSTRACT 
 
Our previous work has shown that EC tubulogenesis requires membrane 
trafficking steps where pinocytic intracellular vacuoles generated at the basal membrane 
are trafficked and proceed to undergo fusion with one another in a perinuclear and 
polarized manner to create the apical luminal membrane.  Here, we examine known 
GTPase regulators of vesicle trafficking events that affect processes such as endocytosis, 
macropinocytosis, vesicle movement along the cytoskeleton and exocytosis.  We identify 
novel roles for the small GTPases Rab3A, Rab3B, Rab8A, Rab11A, Rab27A, RalA and 
RalB and Caveolin-1 in co-regulating endothelial cell (EC) lumen and tube formation in 
3D collagen matrices.  siRNA suppression of individual GTPases such as Rab3A, 
Rab8A, and RalB markedly inhibit tubulogenesis, while even greater blockade is 
observed with combinations of siRNAs such as Rab3A and Rab3B, Rab8A and Rab11A, 
and RalA and RalB.  In contrast, knockdown of the endocytosis regulator, Rab5A, fails to 
inhibit EC tube formation.  These GTPases have been strongly implicated in either 
vesicle trafficking (Rab11A, Rab8A) or membrane exocytosis events (Rab3 and Ral 
isoforms). Interestingly, Caveolin-1 and RalA strongly label vacuoles and localize to the 
apical membrane surface and subapical region as they coalesce to form the luminal 
membrane. In contrast, Cdc42 and Rab11A strongly localize in a perinuclear, subapical 
region where intracellular vacuoles accumulate and fuse during lumen formation.  
Inhibition of Src or Rac activity through use of chemical inhibitors greatly reduces 
pinocytic intracellular vacuolization and thus markedly impairs EC tubulogenesis 
whereas inhibition of MT1-MMP activity inhibited fusion of vacuoles/vesicles during EC 
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tubulogenesis implicating an important role for its activity in regulating lumen formation 
downstream of pinocytic intracellular vacuolization. Thus, EC tubulogenesis is dependent 
on a series of small GTPases to coordinate polarized membrane trafficking events to 
generate, deliver, and fuse pinocytic intracellular vacuoles at the EC apical membrane 
surface during lumen and tube formation. 
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INTRODUCTION 
 
Critical steps during early vasculogenesis and lumen formation include both the 
establishment of asymmetric cytoskeletal polarization and the trafficking of pinocytic 
intracellular vacuoles to create an apical membrane surface1-9. Importantly, the 
asymmetric distribution of cytoskeletal components serves a critical function for 
organization of membrane trafficking to correct locations within the cell10, 11 and recent 
work from our laboratory has demonstrated a necessary function for the subapical 
distribution of tubulin modifications, i.e. acetylated tubulin and detyrosinated tubulin, 
during EC lumen formation and vasculogenesis7 (Chapter II). During vascuologenesis, 
membrane trafficking events occur along acetylated-tubulin enriched microtubules to 
organize intracellular vacuoles that coalesce with one another to form a lumen and apical 
membrane surface and this is controlled in part by the activity of small GTPases and their 
downstream effectors1, 2, 7, 12-16 (Chapter II). An important direction for the advancement 
of this work is understanding how the necessary steps for lumen formation, i.e. 
intracellular vacuolization, directed trafficking of vacuoles and vesicles along an 
asymmetrically polarized cytoskeleton, and coalescence of vacuoles/vesicles to form the 
lumen, are spatially and temporally controlled by different molecular regulators of 
membrane trafficking events. Furthermore, a significant challenge in the field has been 
identifying molecules in ECs that define both the apical membrane surface and the 
subapical domain and what role they have in regulation of EC lumen formation9.  
In addition to macropinocytic mechanisms, mammalian cells are capable of 
transporting membrane compartments through additional endocytic mechanisms, e.g. 
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clathrin-mediated, caveolae/caveolin-1 dependent, clathrin independent, phagocytosis 
and others, as well as through exocytic mechanisms17. The Rab family of GTPases 
comprises the largest family of small GTPases and Rabs are key regulators of membrane 
trafficking events in eukaryotic cells18-21. Recent work in epithelial models of lumen 
morphogenesis have identified a critical role for Rab11A-Rab8A activity in mediating 
trafficking of vesicles to the apical membrane initiation site and Rab27/Rab3/Rab8 
regulation of vesicle tethering and fusion to form a single lumen during de novo lumen 
formation22-24. In ECs Rab3B, Rab3D, Rab27A and the Ras family GTPase RalA were 
identified to associate with exocytic secretory granules known as Weibel-Palade bodies 
that are released from ECs to regulate thrombosis and inflammation25-30. Interestingly, it 
was shown that immunostaining of von Willebrand Factor, a component Weibel-Palade 
bodies, labeled intracellular vacuole compartments during EC lumen formation 31, 
possibly implicating a role for the above exocytic GTPase regulators during EC lumen 
morphogenesis. Caveolin-1 is also highly expressed in ECs and has been shown to 
regulate capillary morphogenesis in vitro and in vivo32-34. Additionally, caveolae in ECs 
have been identified to associate with key regulators of EC morphogenesis such as Src, 
Yes, Raf, MEK, Ras and Rap132, 35, 36. Together, these results implicate a role for Rab and 
Ral GTPases and Caveolin-1 to control of membrane trafficking events during EC lumen 
formation and tubulogenesis although the details of this mechanism are unclear. 
In this study, we present novel information characterizing the role of regulators of 
membrane trafficking events during EC lumen formation and tubulogenesis. Our studies 
have identified novel roles for the GTPases Rab3A, Rab3B, Rab8A, Rab11A, Rab27A, 
RalA and RalB as well as Caveolin-1 during this process and siRNA suppression of RalB 
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combined with Rab3A, Rab3B, Rab27A and RalA markedly impairs the ability of ECs to 
undergo tubulogenesis. Furthermore, we show that intracellular vacuoles are highly 
enriched in Caveolin-1 and RalA and we detect targeting of Src to vacuoles as well. 
Caveolin-1 and RalA then proceed to target to the apical membrane surface while Src and 
the GTPases Cdc42, Rab11A and Rab27A are localized in the subapical domain. Finally, 
we show that Src and Rac activity are necessary for the generation of intracellular 
vacuoles and MT1-MMP activity regulates coalescence of vacuoles downstream of this 
step. Thus, separate events in EC lumen formation controlling intracellular vacuole 
generation, polarized trafficking and fusion occur in coordination with key lumen 
signaling pathways to control how ECs form cell-lined tube networks in 3D extracellular 
matrices. 
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MATERIALS AND METHODS 
 
Reagents 
 Stem cell factor (SCF), stromal cell-derived factor 1 alpha (SDF-1α) and 
interleukin-3 (IL-3) were obtained from R&D systems (Minneapolis, MN). Chemical 
inhibitors PP3 and EHT 1864 were obtained from TOCRIS Bioscience (Bristol, United 
Kingdom). Ascorbic acid and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) were 
obtained from Sigma-Aldrich (St. Louis, MO). Recombinant fibroblast growth factor 2 
(FGF-2), antibody against β-Actin and the chemical inhibitors PP2 and GM6001 were 
obtained from EMD Millipore (Billerica, MA). Antibodies against Rab3B, Rab3D, 
Rab11A and Rab27A were obtained from Abcam (Cambridge, MA). Antibodies against 
Caveolin-1, Rab3A, Rab5 and Rab8 were obtained from Cell Signaling Technology 
(Danvers, MA). An antibody against RalA was obtained from BD Biosciences (San Jose, 
CA). GFP-RalA and S-Ch-Cdc42 adenoviruses were generated and utilized as described 
previously37(Chapter II). 
 
Vasculogenic tube assembly assays 
 Human umbilical vein endothelial cells were obtained from Lonza (Walkersville, 
MD) and were cultured (passage 3-6) as described previously38. 
 For use in siRNA-mediated knockdown assays, siRNA transfected ECs were 
harvested and then suspended at 2 x 106 cells/mL in 2.5 mg/mL collagen type I matrices 
and assays were performed as described previously39, 40. In brief, SCF, IL-3, SDF-1α and 
FGF-2 were added at 200 ng/mL directly into collagen type I. Cultures were then fed 
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with media containing reduced serum supplement II (RSII), ascorbic acid and FGF-2 at 
40 ng/mL. Cultures were allowed to assemble into capillary networks for 72 hours when 
cultures were fixed in 3% glutaraldehyde in PBS or collected for additional processing. 
Following fixation, cultures were then stained in 0.1% toluidine blue in 30% methanol 
for use in imaging and statistical analysis. 
 For use in confocal microscopy imaging analysis, ECs were first infected with 
recombinant adenoviruses as described previously12. Infected ECs were then harvested 
and suspended at 2 x 106 cells/mL in 3.75 mg/mL collagen type I matrices and assays 
were performed as described previously38. In brief, cultures were fed with media 
containing RSII, ascorbic acid, FGF-2 at 40 ng/mL and TPA at 50 ng/mL. Cultures were 
allowed to assemble into capillary networks over a period of 0-48 hours when cultures 
were fixed in 2% paraformaldehyde in PBS at the indicated time points. Fixed cultures 
were then stained before use in confocal fluorescent microscopy imaging. 
 
EC siRNA suppression 
siRNA suppression protocols using the siRNA list below were performed as 
described previously38. ECs were allowed to recover for 48 hrs and transfection was 
repeated. ECs were then allowed to recover overnight before being harvested for use in 
3D assays or collected for protein expression analysis using standard western blotting 
techniques.  
siRNAs from Ambion are as follows: 
Control (AM4637) Silencer Select Negative Control #2 
Rab3A (s11666) 5’-CCAUCACCACCGCAUACUA-3’ 
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Rab3B (s11669) 5’-GCUUCAUUCUGAUGUAUGA-3’ 
Rab3D (s18326) 5’-AGGAGAACAUCAAUGUGAA-3’ 
Rab5A (s11678) 5’-GGAAGAGGAGUAGACCUUA-3’ 
Rab8A (s8679) 5’-GCAAGAGAAUUAAACUGCA-3’ 
Rab11A (s16703) 5’-GAGAUUUACCGCAUUGUUU-3’ 
Rab27A (s11693) 5’-GCCUCUACGGAUCAGUUAA-3’ 
RalA (s11758) 5’-GGACUACGCUGCAAUUAGA-3’ 
RalB (s11762) 5’-CAUGAAUCCUUUACAGCAA-3’ 
Caveolin-1 (s2446) 5’-GCUUCCUGAUUGAGAUUCA-3’ 
 
Generation of recombinant adenoviruses 
Rab11A and Rab27A were amplified from cDNA obtained from Missouri S&T 
cDNA Resource center (Rolla, MO) and mCherry-Rab5A and sfGFP-Caveolin1 fusion 
constructs were amplified from cDNA obtained from Addgene (Cambridge, MA) and Src 
was amplified from cDNA obtained from Open Biosystems (Open Biosystems, GE 
Dharmacon, Lafayette, CO). Standard restriction digest cloning protocol was used to 
subclone amplified Rab11A and Rab27A into pmCherry-C1 plasmid and Src into 
pAcGFP-N1 plasmid (Clontech, Mountain View, CA) using EcoRI-HF and BamHI-HF 
and XhoI and AgeI-HF restriction enzymes respectively (New England Biolabs, Ipswich, 
MA). Amplified S-epitope (S) tagged S-Ch-Rab5A, S-Ch-Rab11A, S-Ch-Rab27A, Src-
GFP-S and sfGFP-Caveolin1 constructs were subcloned into pShuttle-CMV expression 
plasmid using NotI-HF and XbaI, SalI-HF and NotI-HF and KpnI-HF and NotI-HF 
restriction enzymes respectively (New England Biolabs). Recombinant adenoviral 
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vectors were then generated41 and propagated as previously described12. The PCR 
primers used are listed below with the upstream primer first followed by the downstream 
primer. 
Rab11A 5’-AGGAATTCTATGGGCACCCGCGACGACGAGTAC-3’ 
5’-AGGGATCCTTAGATGTTCTGACAGCACTGCAC-3’ 
Rab27A 5’-AGGAATTCTATGTCTGATGGAGATTATGATTACC-3’ 
5’-AGGGATCCTCAACAGCCACATGCCCCTTTCTCC-3’ 
Src 5’-AGCTCGAGATGGGTAGCAACAAG-3’ 
5’-AGACCGGTATGAGGTTCTCCCCG-3’ 
Primers used for subcloning into the pShuttle-CMV plasmid are as follows. The first 
primer (S-Cherry) is an upstream primer followed by downstream primers for S-Ch-
Rab5A, S-Ch-Rab11A and S-Ch-Rab27A. The following sets are pairs of upstream and 
downstream primers for Src-GFP-S and sfGFP-Caveolin1 respectively. 
S-Cherry 5’-AGGCGGCCGCACCATGGCAAAAGAAACCGCTGCTGCGAAATTTG 
AACGCCAGCACATGGACTCGATGGTGAGCAAGGGCGAGGAG-3’ 
Rab5A 5’-AGTCTAGATTAGTTACTACAACACTGATTCCTGGTTGGC-3’ 
Rab11A 5’-AGTCTAGATTAGATGTTCTGACAGCACTGCAC-3’ 
Rab27A 5’-AGTCTAGATCAACAGCCACATGCCCCTTTCTCC-3’ 
Src-GFP-S 5’-AGGTCGACATGGGTAGCAACAAGAG-3’ 
5’- AGGCGGCCGCTTACGAGTCCATGTGCTGGCGTTCAAATTTCGCAGCAG 
CGGTTTCTTTACCAGACTTGTACAGCTCATCCATGCCGTG-3’ 
sfGFP-Caveolin1 5’-AGGGTACCACCATGGTGAGCAAGGGCGAGGAGCTGTTC-3’ 
5’-AGGCGGCCGCTTATATTTCTTTCTGCAAGTTGATGCGG-3’ 
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Microscopic imaging and analysis 
Fluorescent microscopic imaging of 3D cultures was performed using a confocal 
microscope (Leica TCS SPE, Leica, Buffalo Grove, IL) using excitation wavelengths of 
405 and 488 or 405, 488 and 561 nm sequentially. High-resolution images were captured 
using a 63X water immersion objective (NA 1.2) utilizing Leica application suite 
advanced fluorescence (LAS-AF) software. Toluidine blue stained 3D cultures were 
imaged using light microscopy on inverted microscopes (Eclipse TE2000-E; Nikon, 
Melville, NY with Photometrics CoolSNAPHQ2 camera, Tucson, AZ, and Olympus 
CKX41 with Olympus DP70 camera, Center Valley, PA). Photographs of cultures were 
analyzed using Metamorph software (Molecular Devices, Sunnyvale, CA) by tracing 
vessel area and lumen area.  
 
Statistical analysis 
 Statistical analysis of selected EC vasculogenic and lumen formation data was 
performed using Microsoft Excel (Microsoft). Statistical significance was set at minimum 
with P < 0.05. Student’s t-tests were used when analyzing two groups within a single 
experiment (with a minimum n=10 from representative experiments or , consolidated 
experiments).  
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RESULTS 
 
Regulators of vesicle trafficking control EC tubulogenesis in 3D collagen matrices 
 Recent work in epithelial models of lumen formation demonstrated a required role 
for Rab11A-Rab8A regulation of apical trafficking of membrane vesicles22, 23 and 
Rab27A/Rab3/Rab8 regulation of vesicle tethering and fusion24. Additionally Rab3 and 
Rab27 were shown to associate with and regulate Weibel-Palade body exocytosis in 
ECs26, 27, 29, 30 whereas Caveolin-1 has been implicated during angiogenesis events in vitro 
and in vivo33. Therefore, we performed a screen of Rab GTPases and Caveolin-1 during 
EC tubulogenesis by siRNA suppression and identified several new regulators of 
membrane trafficking events associated with this process (Fig. 3.1). Our data implicates a 
key role for Rab3A, Rab3B, Rab8A, Rab11A, Rab27A and Caveolin-1 during this 
process where Rab3A and Rab8A knockdown have the most marked effects. In contrast, 
Rab5A knockdown showed no effects whereas Rab3D may be inhibitory as knockdown 
stimulated EC tubulogenesis. Using combinations of siRNAs, we demonstrated that 
combined knockdown of Rab8A with Rab11A or Rab27A had a greater blocking effect 
compared to knockdown of Rab8A alone and that combined knockdown of Rab27A and 
Caveolin-1 had a greater blocking effect than knockdown of Rab27A or Caveolin-1 
alone. Furthermore, these particular combined knockdowns had the greatest blocking 
effect compared to other siRNA combinations tested (Fig. 3.2 and Fig. 3.3). This data 
suggests that differential regulation of trafficking events by Rab3A, Rab3B, Rab8A, 
Rab11A, Rab27A and Caveolin-1 appears to be necessary for ECs to form lumens and 
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assemble into capillary networks in 3D matrix environments whereas a role for Rab5A is 
not supported. 
 
The exocytosis regulators RalA and RalB control EC tubulogenesis 
 Because we observed strong blocking effects of tubulogenesis with siRNA 
suppression of Rab3A, Rab3B and Rab27A (Fig. 3.1), we addressed the role of both 
isoforms of the Ral GTPases, which are known to regulate exocytosis through their 
association with the members of the exocyst complex, Sec5 and Exo8442-47 and with 
Weibel-Palade bodies in ECs25. siRNA suppression of either RalA or RalB blocked EC 
tubulogenesis with a more prominent effect observed with knockdown of RalB (Fig. 3.4). 
Using additional combinations of siRNAs, we show that combined knockdown of RalB 
with Rab3A, Rab3B, Rab27A, and RalA had the greatest blocking effects compared to 
any of the blocking effects observed with individual siRNA suppression of these 
GTPases or other combinations (Fig. 3.5 and Fig. 3.6). We also show that combined 
siRNA suppression of Rab3A and Rab8A has a greater blocking effect than suppression 
of Rab3A alone (Fig. 3.5 and Fig. 3.6). Together, this data suggests that RalA and RalB 
are critical regulators of EC lumen morphogenesis. The synergistic effects of RalB 
knockdown with other GTPases associated with regulation of exocytosis also suggests 
that these molecules have important, distinct functional roles from one another in control 
of lumen formation and may operate at different stages. Furthermore, our results from 
combined siRNA suppression of Rab3A and Rab8A demonstrates a possible role for 
regulation of differing endocytic and exocytic membrane trafficking steps during EC 
tubulogenesis.  
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Caveolin-1- and RalA-enriched intracellular vacuoles are trafficked from the basal 
membrane surface to form the apical luminal membrane during EC tubulogenesis 
 It is necessary during lumen formation for cells to establish an apical membrane 
surface distinct from the basal membrane surface that interfaces with the extracellular 
matrix environment. A critical area of focus in our lab is defining how the apical 
membrane surface is created and stabilized during EC lumen formation and we have 
made considerable progress in this field of study. We have previously reported that the 
microtubule plus-end proteins EB1, p150Glued, and Clasp1 regulate polarization of 
acetylated tubulin and detyrosinated tubulin subapically during EC lumen formation7. We 
have also demonstrated that acetylated tubulin is highly co-localized with Cdc42 in the 
subapical domain and that intracellular vacuoles accumulate around this region as they 
are trafficked along these modified tubulin tracks to the apical membrane surface. 
Additionally, we also showed that key regulators of lumen morphogenesis, such as Rac1, 
Rac2, k-Ras, Rap1B, phospho-C-Raf and Rasip1 are localized at the subapical domain or 
the apical membrane surface during EC tubulogenesis. In contrast, F-actin visualized by 
staining with fluorescent conjugated phalloidin is polarized in a basal location (Chapter 
II). 
 To investigate the subcellular localization of additional key regulators of EC 
lumen formation and molecules associated with membrane trafficking events, we created 
a panel of recombinant adenovirus reagents expressing mCherry-fusion or GFP-fusion 
proteins as shown in Table 3.1. We then used multiple combinations of these reagents to 
assess whether these molecules co-localize with one another over time during different 
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stages of EC lumen morphogenesis. Here, by using GFP-RalA and sfGFP-Caveolin1 
constructs we show that Caveolin-1 and RalA strongly localize to intracellular vacuoles 
generated from the basal membrane surface that are trafficked apically and fuse within a 
perinuclear region to form the EC apical luminal membrane over time (Fig. 3.7 and Fig. 
3.8). Additionally, using a Src-GFP-S construct we show that Src also targets to 
intracellular vacuoles during this process (Fig. 3.9). As the intracellular vacuoles coalesce 
to form the lumen during later events, we also show that Caveolin-1 and RalA target to 
the apical membrane surface while Src is more localized within the subapical domain. In 
contrast, use of S-Ch-Cdc42, S-Ch-Rab11A, S-Ch-Rab27A and S-Ch-Rab5A constructs 
showed that Cdc42, Rab11A, Rab27A and Rab5A all show targeting ability to the 
subapical domain region (Fig. 3.7, Fig. 3.8 and Fig. 3.9). During early EC lumen 
formation, Rab11A appears to localize to vesicles in a punctate manner that accumulate 
in a polarized, perinuclear region whereas Rab27A is initially diffuse throughout the 
cytoplasm and Rab5A is localized to more diffuse, punctate regions. Furthermore, it 
appears that as intracellular vacuoles are being trafficked apically that they accumulate 
around these perinuclear regions where Rab11A and Cdc42 are strongly localized. 
 
Pinocytic intracellular vacuolization is required for EC tubulogenesis 
 Both Rac1 and Src activity have been associated with macropinocytosis48-50 and 
we have previously reported the required activity of Src and Rac1 during EC 
tubulogenesis in 3D matrices12-14. Our lab has also shown that blockade of membrane 
type I matrix metalloproteinase (MT1-MMP) activity dramatically interferes with EC 
tubulogenesis by inhibiting the formation of vascular guidance tunnels in 3D matrices51. 
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Furthermore, MT1-MMP activity is required for Cdc42 activation during EC 
tubulogenesis15. However, whether MT1-MMP activity influences downstream 
membrane trafficking events during EC tubulogenesis is unclear. To address how Src, 
Rac, and MMP activity regulate different steps involved in generation, apical trafficking, 
and fusion of vacuoles during EC lumen formation, we utilized chemical inhibitors in 
combination with a recombinant adenovirus construct expressing sfGFP-Caveolin1 and 
high-resolution confocal microscopy analysis to assess how these separate steps are 
controlled.  We first treated EC cultures with chemical inhibitors targeting Src (PP2 and 
its negative control PP3), Rac GTPases (EHT 1864), and MMPs (GM 6001) and show 
that addition of PP2, EHT 1864, or GM 6001 dramatically blocks EC lumen formation 
after 24 hours of culture (Fig. 3.10A). Confocal microscopy analysis of EC cultures 
expressing sfGFP-Caveolin1 construct treated with the above chemical inhibitors show 
that during early stages of EC lumen morphogenesis, inhibition of Src or Rac activity 
greatly impairs the ability of ECs to form pinocytic vacuoles, as visualized by Caveolin1 
targeting to vacuoles in Control and PP3 treated cultures, and thus markedly inhibits 
lumen formation (Fig. 3.10B). In contrast, vacuoles are observed in GM 6001 treated 
cultures, but they fail to fuse to create the apical luminal membrane (Fig. 3.10B, lower 
panel). These results suggest that the generation of pinocytic vacuoles is required for EC 
tubulogenesis and that Rac and Src activity are key regulators of this process. 
Additionally, MMP activity, likely through MT1-MMP, is required in downstream events 
controlling either membrane trafficking or vacuole coalescence.  
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DISCUSSION 
 
 Intracellular vacuolization is a critical mechanism during EC tubulogenesis and 
capillary assembly3-6. Important to this process is addressing the mechanisms of how ECs 
are able to generate intracellular vacuoles, traffic them and control fusion of individual 
vacuoles with one another to create an apical luminal membrane that is matured through 
continued delivery of intracellular vacuoles and vesicles during the course of lumen 
formation. In the work presented here, we identify novel roles for Rab3A, Rab3B, 
Rab8A, Rab11A, Rab27A, RalA and RalB small GTPases and Caveolin-1 in controlling 
EC lumen formation in coordination with Src, Rac1 and Cdc42 activity as shown in 
Figure 3.11. We also demonstrate critical roles for key regulators of tubulogenesis in 
controlling apical-basal polarization of ECs during this process as Caveolin1, RalA and 
Src target to intracellular vacuoles and the developing apical membrane, whereas Cdc42, 
Rab11A and Rab27A localize within the subapical domain. Finally, we demonstrate that 
generation of intracellular vacuoles is necessary for EC lumen formation via Src kinase 
and Rac activity, whereas MMP activity, likely though MT1-MMP, potentially has an 
important downstream function in mediating vacuole fusion events in addition to its role 
in creating vascular guidance tunnels necessary for EC tubulogenesis51.  
 As Rab GTPases are the largest family of small GTPases and regulate a variety of 
membrane trafficking events20, 21, they have become an important target of investigation 
for studying how membrane material is delivered to a nascent apical domain during de 
novo lumen formation. Recent work in Madin-Darby Canine Kidney cyst models of 
epithelial lumen formation have implicated roles for Rab11A-Rab8A and 
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Rab27/Rab3/Rab8 pathways in controlling de novo development of lumen cysts22, 24. 
However, a role for Rab GTPases in regulation of endothelial lumen formation and 
tubulogenesis has not been previously reported. Here, we show that siRNA suppression 
of Rab3A, Rab3B, Rab8A, Rab11A or Rab27A impairs endothelial tubulogenesis in 3D 
collagen matrices where suppression of Rab3A and Rab8A possess the strongest blocking 
effects. Additionally, we also show that siRNA suppression of Caveolin-1, RalA and 
RalB blocks EC tubulogenesis supporting the conclusion that multiple GTPases, as well 
as Caveolin-1, regulate critical membrane trafficking events necessary for EC 
tubulogenesis. In contrast, we show evidence suggesting that Rab3 isoforms have 
important functional differences in this process as siRNA suppression of Rab3D 
stimulated EC tubulogenesis. However, Rab5A regulation of macropinocytosis or 
clathrin-mediated endocytosis is not involved, as suppression of Rab5A had no effect on 
tubulogenesis. In support of the conclusion that these molecules possess different 
functional roles during different stages of EC tubulogenesis, combined siRNA 
suppression of Rab8A and Rab11A, Rab8A and Rab27A, and Rab27A and Caveolin1 
had stronger blocking effects compared to individual suppression of Rab8A, Rab27A, or 
Caveolin-1. Additionally, we show that combined siRNA suppression of RalB with 
Rab3A, Rab3B, Rab27A and RalA markedly blocks tubulogenesis, implicating the 
critical importance of RalB function during this process. Together, our results show 
similar functional requirements of Rab3, Rab8A, Rab11A and Rab27A compared to what 
has previously been reported in MDCK cyst models. In these models, it was shown that 
Rab11A-Rab8A acts in a signaling pathway to activate Cdc42 activity and association 
with the Par3/Par6/aPKC complex as well as the exocyst to deliver vesicles apically22 
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whereas Synaptotagmin-like protein (Slp)-4a controls vesicle tethering and fusion in 
conjunction with Rab27/Rab3/Rab8 and the SNARE syntaxin-324. However, whether 
these effectors act downstream of Rab3, Rab8A, Rab11A and Rab27A during EC 
tubulogenesis is unclear. Identification of the molecular mechanisms regulated by these 
GTPases, Caveolin1, RalA and RalB as well as identification of the mechanisms 
controlling their activity is of great importance and is the focus of ongoing studies.   
 Our work presented here also identifies new regulators of EC polarity and 
trafficking of pinocytic intracellular vacuoles during tubulogenesis. We show that as 
lumen formation progresses, ECs accumulate intracellular vacuoles generated from the 
basal membrane surface that are enriched in Caveolin-1 and RalA and we also 
demonstrate that Src targets to vacuoles. These vacuoles are oriented in a polarized, 
perinuclear region that proceed to traffic apically and fuse to create the apical luminal 
membrane where Caveolin-1 and RalA are targeted to. In contrast, we observe that 
Cdc42, Rab11A, Rab27A and Rab5A target to the subapical domain. We previously 
demonstrated that during early EC lumen formation, Cdc42 is highly co-localized with 
acetylated tubulins as intracellular vacuoles accumulate around this region and are 
trafficked along modified tubulin tracks (Chapter II). Interestingly, Rab11A appears 
punctate and highly localized within a similar region suggesting that Rab11A and 
possibly Rab8A positive vesicles traffic along these modified tubulin tracks and regulate 
apical trafficking of vacuoles as well, and this will be investigated in future studies. 
Additionally, Caveolin-1 has been shown to be not only a target of Src phosphorylation52 
but also a negative regulator of Src kinase activity through cooperation with C-terminal 
Src kinase (Csk) binding protein53. Because both Caveolin-1 and Src target to 
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intracellular vacuoles, this suggests that these molecules may interact and potentially 
regulate the activity of one another. However, further work is required to elucidate their 
possible mechanism of interaction. We also show by use of chemical inhibitors of Src 
and Rac that these molecules block lumen formation. This is accomplished by strongly 
inhibiting pinocytic intracellular vacuolization, which is necessary for EC tubulogenesis, 
and this reflects results previously reported using chemical inhibitors or siRNA 
suppression techniques directed to Src and Rac112-14. We also present for the first time a 
possible novel function for MT1-MMP activity in downstream events of EC lumen 
formation as inhibition of MMP activity did not block pinocytic intracellular 
vacuolization, but inhibited fusion of vacuoles with one another and expansion of the 
lumen. The mechanism of this function is unclear and will be pursued in future work.  
Thus, EC tubulogenesis and lumen formation is a highly coordinated signaling 
event regulated by a number of GTPases and their downstream effectors with distinct 
functional differences as supported by the work presented here and what our lab and 
others have previously reported5, 6 (Chapter II). However, the molecular mechanisms of 
these signaling pathways and their interactions with one another are not well understood 
and it is of great importance in the vascular biology field to continue these investigations 
so that they may be elucidated.  
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FIGURES AND LEGENDS 
 
FIGURE 3.1 
 
 
 
Figure 3.1. Identification of key membrane trafficking regulators that control EC 
tubulogenesis in 3D matrices. (A) EC cultures were transfected with control siRNA or 
siRNA directed to Rab3A, Rab3B, Rab3D, Rab5A, Rab8A, Rab11A, Rab27A and 
Caveolin-1, and then were suspended in 3D collagen matrices for 72 hr. before fixation, 
staining, and photography. Data are normalized to control samples and are reported as 
average vessel area per high-powered field (HPF) ± standard deviation (SD) (n=36, p < 
.01). Asterisk indicates significance compared to control cultures. (B) Lysates generated 
from transfected cultures in (A) were used in Western blots to assess specific protein 
knockdown versus control. (C) Representative images from transfected cultures in (A) 
are shown. Bar equals 100 µm.  
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FIGURE 3.2 
 
 
 
Figure 3.2. Combined siRNA suppression of Rab GTPases and Caveolin-1 delineate 
functional differences during EC tubulogenesis. Individual EC cultures were transfected 
with the indicated siRNAs singly or in combinations of two, and suspended in 3D 
collagen matrices for 72 hr. before being fixed, stained, photographed and quantified. 
Data are normalized to control samples and are presented as average vessel area per HPF 
± SD (n=36). Asterisks indicate significance at p < .01 to control whereas squares 
indicate significance at p < .01 to Rab8A, Rab11A, or Rab27A respectively, circles 
indicate significance at p < .05 to Rab11A, and triangles indicate significance at p < .01 
to Caveolin-1. 
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FIGURE 3.3 
 
    
 
Figure 3.3. EC tubulogenesis requires differential regulation of membrane trafficking 
events by Rab8A, Rab11A, Rab27A and Caveolin-1. ECs were transfected with control 
siRNA or the indicated combinations of siRNAs and suspended in 3D collagen matrices 
for 72 hr. before being fixed, stained and photographed. Representative images of 
cultures are shown. Bar equals 100 µm.  
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FIGURE 3.4 
 
 
 
Figure 3.4. RalA and RalB are required for EC tubulogenesis in 3D matrices. (A) EC 
cultures were transfected with a control siRNA or siRNA directed to RalA or RalB and 
cultures were suspended in 3D collagen matrices for 72 hr. before being fixed, stained, 
photographed and quantified. Data are normalized to control samples and are reported as 
average vessel area per HPF ± SD (n=22, p < .01). Asterik indicates significance to 
control samples. (B) Lysates generated from transfected cultures in (A) were used in 
Western blots to assess specific protein knockdown versus control. (C) Representative 
images from transfected cultures in (A) are shown. Bar equals 100 µm.  
 
 
 
 
 
 
	 129	
FIGURE 3.5 
 
 
 
Figure 3.5. Functional differences of small GTPase regulators of exocytosis and 
endocytosis are critical during EC tubulogenesis in 3D matrices. Individual EC cultures 
were transfected with the indicated siRNAs singly or in combinations of two, and 
suspended in 3D collage matrices for 72 hr. before being fixed, stained, photographed 
and quantified. Data are normalized to control samples and are presented as average 
vessel area per HPF ± SD (n=22). Asterisks indicate significance at p < .01 to control 
whereas squares indicate significance at p < .01 to Rab3A, Rab3B, Rab27A, or RalA 
respectively, circles indicate significance at p < .05 to Rab3A, and triangles indicate 
significance at p < .01 to RalB. 
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FIGURE 3.6 
 
 
 
Figure 3.6. RalB is a critical regulator of EC tubulogenesis functionally distinct from 
Rab3A, Rab3B, Rab27A and RalA. ECs were transfected with control siRNA or the 
indicated combinations of siRNAs and suspended in 3D collagen matrices for 72 hr. 
before being fixed, stained and photographed. Representative images of cultures are 
shown. Bar equals 100 µm.  
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TABLE 3.1 
 
 
 
Table 3.1. Generation of recombinant adenovirus constructs to assess subcellular 
localization and polarization of key regulators of EC tubulogenesis and membrane 
trafficking during EC lumen formation.  
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FIGURE 3.7 
 
 
 
Figure 3.7. Caveolin-1 targets to pinocytic intracellular vacuoles and the apical 
membrane surface during EC tubulogenesis in 3D matrices. ECs were infected with 
recombinant adenovirus carrying sfGFP-Caveolin1 in combination with recombinant 
adenoviruses expressing S-Ch-Cdc42 (top row), S-Ch-Rab11A (middle row), or S-Ch-
Rab27A (bottom row) and were allowed to form vacuoles and lumens in 3D collagen 
matrices for 3-48 hr. to visualize this process. Fixed cultures were then analyzed by 
confocal microscopy and representative images are shown. White arrowheads indicate 
targeting of Caveolin-1 to the apical membrane surface and subapical distribution of 
Cdc42, Rab11A or Rab27A. v indicates representative examples of vacuoles containing 
Caveolin-1. L indicates the EC lumen space. Bar equals 20 µm. 
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FIGURE 3.8 
 
 
 
Figure 3.8. RalA targets to pinocytic intracellular vacuoles and the apical membrane 
surface during EC tubulogenesis in 3D matrices. ECs were infected with recombinant 
adenovirus carrying GFP-RalA in combination with recombinant adenoviruses 
expressing S-Ch-Cdc42 (first row), S-Ch-Rab11A (second row), S-Ch-Rab27A (third 
row) or S-Ch-Rab5A (fourth row) and were allowed to form vacuoles and lumens in 3D 
collagen matrices for 3-48 hr. to visualize this process. Fixed cultures were then analyzed 
by confocal microscopy and representative images are shown. White arrowheads indicate 
targeting of Ral-A to the apical membrane surface and subapical distribution of Cdc42, 
Rab11A, Rab27A or Rab5A. v indicates representative examples of vacuoles containing 
RalA. L indicates the EC lumen space. Bar equals 20 µm. 
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FIGURE 3.9 
 
 
 
Figure 3.9. Src targets to pinocytic intracellular vacuoles and the subapical domain 
during EC tubulogenesis in 3D matrices. ECs were infected with recombinant adenovirus 
carrying Src-GFP-S in combination with recombinant adenoviruses expressing S-Ch-
Cdc42 (top row), S-Ch-Rab11A (middle row), or S-Ch-Rab27A (bottom row) and were 
allowed to form vacuoles and lumens in 3D collagen matrices for 3-24 hr. to visualize 
this process. Fixed cultures were then analyzed by confocal microscopy and 
representative images are shown. White arrowheads indicate subapical distribution of Src 
and Cdc42, Rab11A or Rab27A. v indicates representative examples of vacuoles 
containing Src. L indicates the EC lumen space. Bar equals 20 µm. 
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FIGURE 3.10 
 
 
 
Figure 3.10. Src and Rac activity regulate pinocytic intracellular vacuolization 
necessary for EC tubulogenesis whereas MT1-MMP activity regulates fusion of 
intracellular vacuoles downstream. (A) Cultured ECs were harvested, suspended in 3D 
collagen matrices and fed with control culture media or media containing either PP2 10 
µM, PP3 10 µM, EHT 1864 10 µM or GM 6001 5 µM and allowed to form vacuoles and 
lumens for 24 hr. before being fixed, stained, photographed and quantified for lumen 
area. Data are normalized to control samples and are reported as average lumen area per 
HPF ± SD (n=10, p < .01). Asterik indicates significance to control samples. (B) ECs 
cultures were infected with recombinant adenovirus carrying sfGFP-Caveolin1 and 
treated with control culture media or culture media containing chemical inhibitors as in 
(A) and were allowed to form vacuoles and lumens over a period of 6-24 hr. Fixed 
cultures were then analyzed by confocal microscopy and representative images are 
shown. L indicates the EC lumen space and v indicates vacuoles. Bar equals 20 µm. 
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FIGURE 3.11 
 
 
 
Figure 3.11. Generation, apical trafficking and fusion of pinocytic intracellular vacuoles 
along modified tubulin tracks is controlled by Cdc42, Rac1, Rab and Ral GTPases in 
coordination with Src and Caveolin-1 during EC tubulogenesis. A schematic diagram is 
shown illustrating key steps in endothelial lumen formation differentially regulated by 
small GTPase, Src kinase and Caveolin-1 signaling. Pinocytic intracellular vacuoles 
containing Src, Rac1, Cdc42, Caveolin-1 and RalA are generated at the basal membrane 
surface where they are then trafficked apically by Rab11A and Rab8A regulated activity 
along acetylated tubulin tracks. Rab3A, Rab3B, Rab27A, RalA and RalB then regulate 
fusion of these vacuoles and other membrane vesicles to form the lumen. 
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CHAPTER IV 
CONCLUSION 
 
 In this work, molecular mechanisms of small GTPase regulation of asymmetric 
cytoskeletal polarization, polarized vacuole/vesicle trafficking and vesicle-to-vesicle 
fusion events during EC lumen formation and tubulogenesis are elucidated through use of 
3D models of vasculogenesis under serum-free, defined conditions in type I collagen 
matrices. These assays have allowed for careful analysis of distinct signaling pathways 
regulated by GTPase activity to control early events of vasculogenesis as well as the 
spatiotemporal activity of key molecules involved in this process. Much of the work 
presented here is focused on the identification of new GTPases, critical downstream 
effectors and upstream regulators of GTPase activity controlling these events. In this 
way, we are able to begin to dissect key signaling pathways involved in asymmetric 
cytoskeletal polarization and lumen formation during EC tubulogenesis downstream of 
growth factor, integrin and matrix metalloproteinase signaling.  
 Previous work in our lab was the first to identify a necessary requirement for 
Cdc42 and Rac1 activity during EC tubulogenesis. We have now shown that Rac2, k-Ras 
and Rap1B activity are necessary during EC lumen formation and capillary assembly in 
addition to Cdc42 and Rac1 (Fig. 2.1). siRNA suppression of Cdc42 in combination with 
k-Ras, Rac2 and Rap1B resulted in the most profound blocking effects (Fig. 2.1) while 
suppression of key downstream effectors PAK2 and PAK4 in different combinations with 
one another or IQGAP1, MRCKβ, β-Pix or Rasip1 resulted in similar effects (Fig. 2.6, 
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Suppl. Fig. 2.2, Suppl. Fig. 2.3). Also, it was shown that increased expression of Cdc42, 
k-Ras particularly, and Rap1B stimulated EC tubulogenesis (Suppl. Fig. 2.1). We have 
also shown results from biochemical pulldown assays identifying multiprotein signaling 
complexes with Cdc42, Rac1, Rac2 and k-Ras with α2 integrin, MT1-MMP and key 
downstream effectors. Additionally, these signals were increased through increased 
expression of WT PKCε, correlating with stimulated EC morphogenesis and lumen 
formation (Fig. 2.2, Fig. 2.7). Thus, we have demonstrated that multiple GTPases and 
GTPase effectors work in concert with critical kinases such as Src, PKCε, Raf, MEK, and 
Erk to control EC tubulogenesis. 
 This notion is also supported by our findings showing that multiple GTPase 
activating proteins are responsible for negatively and positively regulating EC 
tubulogenesis. We have now shown that activation of endogenous Cdc42/Rac through 
siRNA suppression of Arhgap31, and k-Ras through suppression of Rasa1 stimulates EC 
tubulogenesis and increases vessel area whereas activation of endogenous RhoA by 
suppression of Arhgap29 inhibits EC tubulogenesis and impairs lumen formation (Fig. 
2.4). Importantly, activation of Cdc42, Rac and k-Ras activity is synergistic and 
stimulates key downstream signaling pathways controlling EC tubulogenesis, such as 
PAK, ERK and other tyrosine kinase activity and tubulin modifications (Fig. 2.2, Fig. 
2.4, Fig. 2.5). In contrast, activation of RhoA inhibits signaling through these pathways 
(Fig. 2.5) suggesting that a critical balance of signaling activity regulated by GTPases 
must be maintained during EC tubulogenesis to form a functional vasculature.  
 This work also demonstrates the critical role of the key GTPases and effectors in 
controlling EC asymmetric polarization during tubulogenesis. Through use of 
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recombinant adenovirus reagents and immunostaining techniques, we showed that 
Cdc42, Rac, k-Ras and phospho-c-Raf accumulate at the developing apical membrane 
(Fig. 2.3, Fig. 2.6, Suppl. Fig. 2.1) and additionally show Rasip1’s ability to target to the 
apical membrane surface both in vitro and in vivo (Fig. 2.6). We have also shown 
evidence that asymmetric polarization of cytoskeletal components by the subapical 
distribution of modified tubulins (particularly acetylated tubulin) and basal distribution of 
F-actin is necessary to direct membrane trafficking of vacuoles/vesicles to the nascent 
apical luminal membrane as vacuoles were observed to accumulate around regions of 
highly localized acetylated tubulin (Fig. 2.3). Finally, we have shown that acetylated 
tubulin and Cdc42 are highly co-localized at the subapical domain and demonstrated that 
the signaling activity of Cdc42, Rac, Ras, PAK and RhoA regulate these critical tubulin 
modifications during EC tubulogenesis (Fig. 2.3, Fig. 2.5, Suppl. Fig. 2.2). In this way, 
the activity of several GTPase signaling pathways in coordination with one another are 
critical in regulating events that control EC tubulogenesis (Fig. 4.1). 
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Figure 4.1. This schematic illustrates key molecular mechanisms regulated by GTPase 
activity controlling the different events in EC lumen formation and tubulogenesis.  
 
 Fundamental to EC lumen formation is the polarized trafficking of vacuoles and 
vesicles to the site of the developing apical luminal membrane from the basal membrane 
surface. Through work presented in this thesis, we identified novel roles for Rab3A, 
Rab3B, Rab8A, Rab11A, Rab27A, RalA and RalB small GTPases and Caveolin-1 in 
controlling endocytic membrane trafficking and exocytic vesicle fusion events (Fig. 3.1, 
Fig. 3.4). In contrast, siRNA suppression of the endocytic regulator Rab5A did not impair 
EC morphogenesis suggesting that Rab5A does not regulate macripinocytic mechanisms 
involved in EC tubulogenesis nor is EC lumen formation dependent on clathrin-mediated 
endocytosis (Fig. 3.1). In continued support of the conclusion that these GTPases possess 
different functional roles during the different stages of EC lumen formation, we observed 
greater blockade of EC tubulogenesis when combinations of siRNAs were used, such as 
Rab3A and Rab3B, Rab8A and Rab11A, RalA and RalB, and Rab3A and Rab8A (Fig. 
3.2, Fig. 3.3, Fig. 3.5, Fig. 3.6).  
 Confocal microscopy analysis of the subcellular localization of several of these 
molecules during EC tubulogenesis demonstrated that they control EC polarization 
through distinct mechanisms. Through use of different combinations of recombinant 
adenovirus reagents carrying fluorescent fusion-proteins, we have shown that Caveolin-
1and RalA strongly target to intracellular vacuoles and the apical membrane and 
subapical domain as vacuoles coalesce (Fig. 3.7, Fig 3.8). However, Cdc42 and Rab11A 
are localized in a perinuclear, subapical region where vacuoles accumulate around (Fig 
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3.7, Fig. 3.8, Fig. 3.9), similar to the distribution of acetylated tubulin (Fig. 2.3) 
suggesting that Cdc42 and Rab11A positive vacuoles/vesicles migrate along modified 
tubulin tracks. Interestingly, we also observed that Src targets to intracellular vacuoles 
(Fig. 3.9) and its functional requirement along with Rac in controlling pinocytic 
vacuolization is supported through blockade of lumen formation and the reduction of 
vacuoles by use of chemical inhibitors (Fig. 3.10). Furthermore, we have shown a novel 
function for MT1-MMP activity downstream of intracellular vacuolization as blockade of 
its activity inhibited fusion of vacuoles/vesicles during EC lumen formation (Fig. 3.10).  
 The studies presented in this thesis represent a novel assessment of the molecular 
mechanisms controlling GTPase regulation during EC tubulogenesis, and are focused on 
delineating the separate steps involved in this process (Fig. 4.2). Through consideration 
of the findings presented here, it is of great importance in the vascular biology field to 
continue to investigate the highly coordinated mechanisms controlling EC polarization 
and lumen formation. In particular, the molecular mechanisms of EC tubulogenesis 
controlled by growth factor, integrin, MT1-MMP, Src family kinase and PKCε activity to 
regulate the downstream signaling pathways controlled by the GTPases identified in this 
work are critical to understanding blood vessel development and maturation, as well as 
what roles these signaling pathways may have in the context of vascular disease states.   
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Figure 4.2. A schematic representation of the ideas and findings presented in this work, 
highlighting GTPase regulation of different steps in EC lumen formation in coordination 
with key kinase and integrin activity.  
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